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1Introduction
Epidemiology of N. gonorrhoeae 
Neisseria gonorrhoeae is an obligate-human pathogen responsible for one of the 
most common sexually transmitted diseases, gonorrhea.  This organism is an aerobic, 
Gram negative cocci-shaped bacterium that is generally arranged in pairs (referred to as 
diplococci).  N. gonorrhoeae is catalase positive, oxidase positive, non-motile, and 
utilizes carbohydrates oxidatively.  The bacterium usually colonizes anogenital mucosal 
membranes, predominately the urethra and the cervix, however, other species of the 
Neisseria genus are found in the mucosal surfaces of the oropharynx and nasopharynx.  
Members of the Neisseria species have potential to colonize or infect most mucosal 
surfaces throughout the human body.  Ocular infections of N. gonorrhoeae can occur due 
to infant passage through an infected birth canal [1].   
Despite effective antibiotic treatment, gonorrhea is still one of the most 
commonly reported sexually transmitted diseases (second only to Chlamydia infections).  
Despite a decrease in occurrence of disease since 1975, the numbers are still high, The 
Centers for Disease Control (CDC) reported 335,104 new cases of gonorrhea in 2003 in 
the United States alone [2] and an estimated 60 million new gonococcal infections were 
reported worldwide in 1999 [3].  The highest rate of gonococcal disease was reported in 
15- to 19-year-old women and 20- to 24-year-old men.  The National Institute of Allergy 
and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) estimates that 
nearly 1 billion dollars a year is spent on treatment of gonococcal infections [4]. 
 
2Clinical aspects of N. gonorrhoeae 
Gonorrhea is primarily spread through sexual contact.  The disease usually 
manifests itself in males as an acute anterior urethritis, accompanied by the onset of 
dysuria and discharge of a purulent exudate.  The disease is the result of recruitment of a 
massive influx of neutrophils to the site of infection.  Rarely, the primary infection can 
spread leading to conditions such as epididymitis, seminal vesiculitis, and prostatitis [5,
6]. 
In women, the disease usually results in increased vaginal discharge, increased 
urinary frequency, abdominal pain, and uterine bleeding.  The symptoms usually pass 
quickly and are largely ignored; therefore ~15% of women infected have the primary 
infection lead to further complications, such as endometritis and pelvic inflammatory 
disease (PID).  Inflammation arising from PID can lead to scarring of the fallopian tubes 
and infertility in as many as 10% of women and also cause ectopic pregnancies [4, 6, 7].  
Furthermore, 0.1% to 3% of female cases can lead to disseminated gonococcal infection 
(DGI) [8].    Unlike men however, women are usually asymptomatic and can serve as a 
reservoir or unknowing carrier of the disease.  Studies have estimated that anywhere from 
25% to 80% of women infected with gonorrhea are asymptomatic carriers and this is one 
of the reasons for the persistence of N. gonorrhoeae in the general population [9]. 
It is also common for patients to be coinfected with Chlamydia trachomitis, the 
causative agent of Chlamydia.  Current data have also suggested that gonococcal 
infection can lead to increased susceptibility to HIV infection, because as gonococcal 
infection increases so does the population of mononuclear cells within the urogenital tract 
which the HIV virus infects [10]. 
3N. gonorrhoeae cannot resist drying outside of the human reservoir and dies 
rather quickly; therefore it requires direct host-to-host transmission.  In males and 
females the primary site of infection (and most common) is a colonization of the 
urogenital epithelium [38].    
Phase (Antigenic) Variation in N. gonorrhoeae 
As a sexually transmitted disease, N. gonorrhoeae can infect a variety of 
anatomical locations each possessing unique physiological properties.  In order for the 
bacterium to survive, it must adapt quickly to these new environments and conditions.  
Gonococci must be able to colonize both the male and female reproductive tract, which 
are drastically different environments, with the latter constantly changing.  The bacteria 
also evade the immune system of the human host by varying the antigens present in the 
outer membrane.  By developing genetic mechanisms that allow for antigenic and phase 
variation, N. gonorrhoeae is able to adapt quickly to various niches while evading the 
immune system through variation in the expression of surface components such as 
opacity proteins, LOS, type IV pili, and iron-utilization receptors.   
 Opacity proteins, more commonly referred to as “Opa,” were named as such 
because the variation in expression of these proteins causes differing colors and opacities 
of the gonococcal colonies when grown on translucent medium [11].  Opa is important 
for adhesion to leukocytes and epithelial cells [12, 13].  N. gonorrhoeae contains at least 
eleven of these genes that are constitutively transcribed.  Each gene contains multiple 
copies of a pentameric pyrimidine DNA repeat (CTCTT) within the coding sequence at 
the 5’ end.  However, the number of repeats present in the gene is subject to frequent and 
precise changes during DNA replication.  This results in reading frame changes that lead 
4to translational control of the expression of these proteins [14, 15].  These pentameric 
repeats result in a phase-variable expression of these genes leading to varying phenotypes 
of gonococcus depending on the Opa protein expressed on the surface. 
 N. gonorrhoeae express long finger-like structures which form type IV pili, and 
these are one of the major antigenic determinants on the cell’s surface.  The pili are 
composed primarily of identical subunits known as pilin [16].  Pili are essential for initial 
attachment of the gonococcus to human epithelial cells and other host cell surfaces; 
therefore they are required for infection to occur [17].  In addition, pili are also required 
for natural competence and auto-agglutination of gonococcal cells. 
 The gene pilE encodes pilin, the major subunit of pili.  The gonococcal genome 
contains multiple expressed copies of the pilin gene within two loci, pilE1 and pilE2, and 
silent copies not expressed because of modifications or truncations of the gene, at the pilS 
loci [18].  Antigenic variation of pili can occur from intragenic homologous 
recombination between the pilS and pilE loci.  This can result in a switch from a piliated 
to a non-piliated variant if the new pilin sequence does not generate a protein or can 
result in a pilin protein different from the old.  The pilin protein contains an N-terminal 
conserved region, a hypervariable region at the C-terminus, and semi-variable regions in-
between.  However the pilin genes in the pilS loci do not posses the sequence encoding 
the N-terminal conserved region.  This can lead to an antigenic variation mechanism of 
small cassettes of the variable regions being exchanged in recombination [19, 20].  Pilin 
variation can lead to changes in immunoreactivity and adhesion functions of the pili, 
which can be observed occurring frequently throughout the infection process [21].       
5pilE is not the only pilin gene that is subject to phase variation. pilC encodes a 
protein that is important for assembly and adherence of the type IV pili.  The expression 
of pilC is governed by a homopolymeric tract of guanines. Frame shifting due to strand-
slippage during DNA replication can occur and functional PilC protein will not be 
produced.  Pilus fibers on the gonococcal surface that lack PilC do not support adherence 
to epithelial cells [22].  Another consequence of non-functional pili besides adherence is 
that N. gonorrhoeae will no longer be naturally competent.  pilC and pilE genes must be 
expressed for the uptake of DNA into the gonococcus by transformation [23].   
Related to pilin, the gonococcal gene, pgtA, contains a poly-guanine tract within 
its coding sequence.  pgtA encodes a galactosyl transferase important for adding a 
galactose residue onto the O-linked N-acetylglucosamine (GlcNAc) of pilin glycan.  
Phase variation of this gene appears to play a role in increased pathogenesis which leads 
to increased virulence of the strain which can cause disseminated gonococcal infection 
[24].    
 LOS molecules are immunogenic glycolipids found on the outer-membrane 
surface of Neisseria species and are also subject to phase variation.  Neisseria LOS 
contains three domains including an outer-membrane-imbedded lipid A molecule, a core 
polysaccharide molecule, and branched oligosaccharide side chains.  This closely 
resembles LPS found in Gram-negative bacteria, such as enterics like E. coli and 
Salmonella species.  However LOS is a truncated version that does not contain an O-
antigen.  LOS is a very important component for Neisseria pathogenesis because it is 
involved in immune evasion, attachment, and host tissue damage [25, 26].  Although the 
precise role of LOS in pathogenesis is still being studied, data have shown that it is 
6important for invasion of human epithelial cells [27].  Also, the different structures of 
LOS appear to be associated with varying levels of pathogenicity in Neisseria. Phase 
variation of LOS genes can increase or decrease the virulence of the gonococci [28-30].   
 LOS biosynthesis is complicated and many genes involved in this process have 
been cloned and characterized.  LOS synthesis is initiated by lgtF, encoding a glycosyl 
transferase that adds glucose to the first heptose molecule in the beginning of the LOS 
chain.  The lgt gene cluster, containing lgtA, lgtB, lgtC, lgtD, and lgtE, is responsible for 
the addition of various sugars to multiple locations on the growing LOS chain.  LOS 
biosynthesis is also subject to phase variation. For example, in strain F62 lgtA, lgtC, and 
lgtD contain poly-guanine tracts of lengths of 17, 10, and 11 base pairs respectively, 
within their coding sequences.  The number of guanine residues in each gene determines 
if a functional product will be encoded as frame shifting and strand-slippage will cause 
translation to occur in or out of frame.  Since the sugars are added to the LOS chain 
sequentially, the loss of function of one of these proteins early in the process can lead to 
truncated versions of LOS [31, 32].  The gene encoding a protein that initiates -chain 
synthesis, lgtG, contains a poly-cytosine tract.  If this gene is out of frame and LgtG is 
not produced, a beta chain will not be added onto the LOS, serving as yet another form of 
variation [33]. 
 N. gonorrhoeae also contains genes that are involved in iron utilization that are 
subject to phase variation.  FetA is a protein receptor that binds ferric enterobactin and 
allows for utilization of this compound as an iron source.  FetA allows the bacterium to 
scavenge for iron in low iron concentration environments.  FetA is an iron-repressible 
protein that is highly expressed in iron-limiting environments but expression is repressed 
7in higher iron environments.  The receptor will also phase vary from a high level of 
expression to a low level of expression or from low to high at a frequency of ~6.9x10-3 
regardless of environmental conditions.  Experimental data show that this phenomenon is 
due to a poly-cytosine tract between that -10 and -35 promoter sequences.  Strand-
slippage in this area and addition or subtraction of cytosines in this region can alter the 
promoter’s effectiveness [34].     
 Poly-guanine tracts play a major role in expression of two receptors that have 
been shown to be imperative for utilization of hemoglobin for a source of iron in N. 
gonorrhoeae. Most gonococcal isolates are unable to utilize human hemoglobin as an 
iron source and cannot grow if hemoglobin is the sole source of iron.  However, a small 
population of isolates has been recognized that can utilize hemoglobin.  The isolates 
express two outer membrane receptors HpuA and HpuB.  The genes that code for these 
receptors, hpuA and hpuB, undergo limited phase variation on a translational level by 
frame-shift mutations in poly-guanine tracts.  A one guanine difference in the coding 
region will either produce a gene that is in frame or out-of-frame, and this will determine 
if a functional receptor is expressed [35].  Phase variation of hemoglobin receptors for 
iron utilization has also been discovered in Neisseria meningitidis where poly-guanine 
tracts play an important role in the expression of receptors HpuAB and HmbR [36, 37].  
Utilization of human hemoglobin as an iron source could become very beneficial for 
gonococcus adapting to survive in the human host.    
 N. gonorrhoeae can selectively attach to non-ciliated epithelial cells in the human 
body, cell types found in the urethra, cervix, pharynx, and conjunctiva.  Infection initiates 
when pili produced by the bacteria interact with and attach to specific host cell surface 
8receptors.  Many of the proteins expressed on the gonococcal outer membrane have 
variable expression levels.  These proteins are expressed at differing levels due to phase 
variation which happens because of pentameric repeats and long homopolymeric 
nucleotide tracts.  Pilin proteins and other proteins involved in attachment in Neisseria 
can be expressed or not expressed due to varied expression of these proteins.  These 
proteins help the bacteria to attach to surfaces, and the variation on the surface helps the 
bacterium evade immune surveillance.   
Opa is a protein expressed on the gonococcal surface that plays an important role 
in pathogenesis.  Opa is important for adhesion to and invasion of epithelial cells.  Opa 
can also bind specifically to receptors on CD4+ T lymphocytes thereby preventing 
activation and proliferation of these immune cells.  LOS molecules are immunogenic 
glycolipids expressed on the surface of the Neisseria species.  LOS is an important outer 
membrane component for Neisseria pathogenesis.  LOS is involved in immune evasion, 
attachment, and tissue damage [25, 26].   
 Phase variation has been well studied in pathogenic Neisseria and is also known 
to occur in other pathogenic species.  In many cases, phase variation occurs because of 
slipped-strand mispairing, which occurs during DNA replication when the DNA 
polymerase ‘slips’ in a tract of repeated nucleotides on the template strand resulting in an 
addition or deletion of one repeat unit in the daughter [39].  Phase variation can occur by 
repeats located in the open-reading frame of the gene resulting in a frame-shift mutation 
or the repeats can be located in the promoter region and alter the effectiveness of that 
promoter when repeats are added or deleted. 
 
9DNA Repair Systems in N. gonorrhoeae 
 A majority of slip-stranded mispairing and phase variation result in DNA 
mismatches, so it was hypothesized that Neisseria does not possess a DNA mismatch 
repair (MMR) pathway.  However, it appears that the bacterium does possess the major 
components of MMR that have been well characterized in E. coli (MutS, MutL, and 
MutH) which can repair most DNA mismatches (except cytosine-cytosine).  There are 
three basic steps in MMR in E. coli: recognition of the DNA mismatch, excision of the 
misincorporated base and DNA surrounding the mismatch, and replacement of the 
excised DNA.  In methyl-directed MMR, MutS forms a clamp around the DNA and scans 
until it reaches a DNA mismatch.  Once MutS has recognized a mismatch, it recruits 
MutL, in an ATP-dependent manner, to the mismatched DNA site.  Next the MutS-MutL 
complex loops the DNA and scans the nearby DNA until it reaches MutH, a MMR 
protein that recognizes and binds to hemi-methylated DNA at a sequence of GATC.  
MutH, aided by the MutS-MutL complex, can then nick the un-methylated strand of 
DNA.  Because the newly synthesized strand will not immediately be methylated, this 
ensures the integrity of the parental strand.  This marks the damaged (or nascent) strand 
for removal and repair.  Helicase II is recruited to unwind the DNA in the direction of the 
mismatch.  Removal of the DNA is catalyzed by ExoVII, RecJ (5’ to 3’), or ExoI (3’ to 
5’) depending on the direction of the mismatch from the ummethylated nick in the DNA 
and removes the nascent (or damaged) strand until reaching MutS still bound to the DNA 
mismatch.  Finally, DNA polymerase III and single-strand binding proteins (SSB) replace 
the excised DNA using the parental strand as a template [40, 41].  Recent studies have 
shown that not only does Neisseria meningitidis possess homologues to MutS, MutL, and 
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MutH, but knock-out mutants of any of these MMR proteins renders the bacterium 
susceptible to higher levels of phase variation.  Thus, it appears that MMR plays an 
important role in the modulating phase variation of Neisseria [42, 43].        
 Research of DNA repair in N. gonorrhoeae is limited.  Some previous studies 
have demonstrated the various repair pathways that are present or lacking.  With the 
availability of the genomic sequence of a N. gonorrhoeae strain, FA1090, a better picture 
of gonococcal DNA repair is emerging.  Studies have established that N. gonorrhoeae 
lacks error-prone repair because it is more sensitive to indirect mutagens that induce a 
postreplicative repair system that is prone to errors.  This system is one of the many 
damage-inducible repair pathways designated as the SOS response [44].  Genes known to 
encode proteins important in the E. coli SOS response were monitored in Neisseria and 
neither recA, uvrA, or uvrB were up-regulated in response to DNA damage from agents 
like UV and methyl methanesulfonate (MMS).  Therefore, it appears that N. gonorrhoeae 
does not possess an SOS-DNA damage inducible repair system [45].  However, recent 
work has giving rise to the idea that N. meningitidis may have a non-classical pathway for 
inducible-DNA repair.  A gene with homology to E. coli’s xseB is part of a regulon that is 
induced in N. meningitidis by contact with host cells.  XseB is a subunit, with XseA, of 
the active exonuclease enzyme ExoVII.  The protein not only modifies the ability of the 
bacterium to deal with DNA damage, but also is responsible for an increase in phase 
variation during induction from bacteria-host cell contact [46].  A non-classical method 
of inducible DNA repair may yet be discovered in Neisseria pathogens. 
Survival of ultraviolet-irradiated N. gonorrhoeae when exposed to photo-
reactivating light did not increase over those incubated in the dark.  Therefore, 
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observations indicate that the gonococcus lacks photoreactivation repair systems [47].  
Other studies have demonstrated that N. gonorrhoeae possesses homologs to genes 
associated with other DNA repair pathways.  N. gonorrhoeae has the ability to remove 
and repair pyrimidine dimers, thus it possesses an active DNA excision repair pathway 
[48].  Genomic data suggest that FA1090 has homologs to genes associated with very-
short patch (VSP) repair, but not much else is know in gonococcus.  However, studies in 
E. coli show that a protein, Vsr, is responsible for correcting T-G mismatches caused by 
spontaneous deamination of 5-methylcytosine (created by methylation of cytosine by the 
protein Dcm) [49].  Also, recent studies have demonstrated that N. gonorrhoeae has two 
proteins, pyrimidine dimer glycosylase I and II, responsible for resolution of DNA 
damage by UV light and oxidative damage [50].     
N. gonorrhoeae also possesses homologues to two recombination repair 
pathways, the RecBCD and RecF-like pathways.  Studies have shown that the gonococcal 
genome contains many of the genes needed for these two major repair pathways and that 
many of them are essential to properly repair damaged DNA in Neisseria. Other studies 
have shown that many of these genes and the encoded proteins are an integral part of 
phase variation in the gonococcus because phase variation of pili on the surface decreases 
or is abolished when these genes are removed.  A RecF-like pathway, including recQ, 
recO, and recX, is involved in altering pilin expression, changing the make-up of the 
outer membrane pili, and thereby aiding in immune avoidance.  The gonococcal RecBCD 
pathway (genes recB, recC, and recD) is involved in DNA transformation and DNA 
repair but not in pilin antigenic variation [51 – 54].  Overall, N. gonorrhoeae contains the 
essential genes and pathways for effective recombinational repair.   
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DNA repair pathways in N. gonorrhoeae have not been completely characterized, 
even though much progress has been made in this area.  Increased understanding and 
insight into gonococcal DNA repair would also enhance our knowledge about 
prokaryotic DNA repair in general as well as deepen our understanding of gonococcal 
pathogenesis.  Many genes in the gonococcal genome contain homopolymeric nucleotide 
repeats that are expected to enhance phase variation.  The DNA repair pathways keep a 
check and balance on phase variation; however a significant amount of phase variation 
occurs and is expected to occur for the gonococcus to survive.  Little is known about the 
control of phase variation, but studies show that it is important for gonococcal 
pathogenesis and survival and that DNA repair pathways are involved.  Unfortunately 
there is a lack of a proper positive selection method for phase variation and measuring 
mutation frequencies.  The goal of this research is to define such a system in N. 
gonorrhoeae strain FA1090 that maintains the integrity of the organism while allowing a 
study of phase variation in homopolymeric nucleotide repeats.  A reporter system was 
created that involved the manipulation of a gonococcal nitroreductase gene and conveyed 
resistance to nitro-aromatic antimicrobials. 
 
Nitroreductase and Nitro-aromatic antimicrobials 
 
Nitroreductases were first studied because of their role in the reduction of 
nitrofurans, a group of compounds that contain a nitro group attached to an aromatic ring.  
Nitrofuran derivatives, such as nitrofurantoin, nitrofurazone, and furazolidone, are used 
as antimicrobials because the reduction by nitroreductases activates these nitro-aromatic 
compounds and leads to bacterial cell death.  Since the starting and end products of this 
reduction lack antimicrobial activity, it is believed that the reduction of such nitro-
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aromatic compounds leads to reactive oxygen intermediates that can damage DNA and 
inhibit bacterial metabolism and cell wall [55, 56].  The precise biological role of the 
nitroreductases is unknown, but strains of bacteria that lack a nitroreductase are more 
resistant to nitrofurans [57].  Nitroreductases have been identified and characterized in a 
wide variety of microorganisms including the pathogens Salmonella typhimurium [58], 
Helicobacter pylori [59], Vibrio harveyi [60], and Escherichia coli [57, 61]. 
 The most characterized nitroreductases are those found in Escherichia coli. E. 
coli encodes two types of nitroreductases, oxygen-insensitive (Type I) and oxygen-
sensitive (Type II) [62].  The E. coli genome contains three genes that encode oxygen-
insensitive (Type I) enzyme activities.  The major component of this activity is encoded 
by the gene nfsA, while two minor components of this activity are encoded by the gene 
nfsB and a gene that has yet to be identified.  NfsA, the nitroreductase encoded by nfsA, is 
dependent on NADPH as an electron donor, while NfsB, encoded by nfsB, can use either 
NADPH or NADH as electron donors [57, 61, 63].  Both NfsA and NfsB are flavin-
mononucleotide (FMN) containing proteins [64, 65].  NfsA shares significant amino acid 
homology with Frp, a flavin reductase of Vibrio harveyi, so much in fact that a single 
amino acid substitution at position 99 transforms NfsA from a nitroreductase into a flavin 
reductase as active as Frp [66].  NfsA has been implicated as being a part of the soxRS 
regulon, because it is regulated in the same manner and induced with the rest of the genes 
contained in the regulon.  The soxRS regulon is induced in response to oxidative stress 
and contributes to the defense against this oxidative stress.  It seems a bit paradoxical that 
a gene that is part of the defense against toxic oxygen radicals when its action is needed 
for activation of nitrofuran antimicrobial agents is based on those same radicals [67].  
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The amino acid sequence of NfsB is similar to FRaseI, a Vibrio harveyi flavin reductase, 
and again a single mutation, which changes one amino acid in the least conserved region, 
will convert NfsB into a flavin reductase similar in activity to FRaseI [68].  
Mutations that render NfsA non-functional in E. coli  result in a low-level of 
resistance to nitrofurans, while mutations that knock-out the function of both NfsA and 
NfsB result in a much higher level of resistance to these nitro-aromatic antimicrobials 
[57].  The same two-step process of increased resistance with two nitroreductases is also 
observed in Helicobacter pylori with mutations in rdxA and frxA that render resistance to 
the prodrug metronidazole, which is reduced by these nitroreductases to a bactericidal 
agent [69]. 
Because loss of function in genes that encode nitroreductases results in resistance 
to nitrofuran antimicrobial agents, it is an ideal starting point for creating a reporter 
system for studying spontaneous mutation.  Potential nitroreductases in Neisseria 
gonorrhoeae FA1090 were identified by database searches and biochemical properties of 
these putative nitroreductases were verified.  Next homopolymeric nucleotide tracts were 
combined with a nitroreductase and out of this a nitrofurantoin-based reporter system was 
created, providing a valuable tool for investigating the genetic basis for spontaneous 
mutation, DNA repair, and phase variation in pathogenic Neisseria.
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Goals of a DNA repair/Phase Variation Reporter System 
 Thesis Focus: To create and characterize a reporter system using homopolymeric 
nucleotide tracts within a nitroreductase to further the understanding of phase 
variation and the systems and proteins that affect it.   
 Specific Goals:
1. Create variants of N. gonorrhoeae FA1090 that contain Poly-Guanine 
tracts in the nitroreductase in lengths of 5 to 12 guanines. 
2. Test each variant for nitroreductase activity after Poly-Guanine 
insertion and test spontaneous mutation frequency of each variant. 
3. Use Denaturing Gradient Gel Electrophoresis (DGGE) to detect frame-
shift mutations in nitrofurantoin resistant mutants 
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Materials and Methods
Bacterial Growth and Storage Conditions 
 
All Neisseria gonorrhoeae strains were grown on GCK agar or GCP broth 
supplemented with Kellogg’s solution and sodium bicarbonate (0.042%) at 37°C with 5% 
CO2. E. coli were grown on LB agar plates or in LB broth.  Broth cultures were grown in 
a rotary shaker at 37°C.  When needed, antibiotics were added to the growth media as 
follows:  spectinomycin at 50 µg/mL and nitrofurantoin at 3 µg/mL.  Strains were stored 
at -80°C after suspension in GCP or LB broth with 20% glycerol added.  Bacterial strains 
with poly-guanine tracts were always passaged directly from freezer stock before assay to 
limit mutation of the poly-guanine tract.  Media components are listed in Table 1 and all 
bacterial strains are listed in Table 2.
Chemicals, Reagents, and Enzymes 
 
Chemicals used in these studies were of analytical grade or better and were 
purchased from Sigma (St. Louis, MO) unless otherwise specified.  Restriction 
endonucleases were purchased from New England Biolabs (Beverly, MA) and were used 
with the supplied buffers according to the manufacturer’s instruction. 
Polymerase Chain Reaction (PCR) 
 
PCR reactions were done using the Expand Long Template PCR System (Roche). 
PCR reactions were cleaned using the QIAquick PCR Purification Kit (Qiagen).  
Oligonucleotide primers were purchased from Integrated DNA Technologies (Coralville, 
IA).  All primers used are listed in Table 3.
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Table 1.  Media composition
GCK 
Gonococcal Base Medium (Difco)   36.0 g 
Bacto-Agar (US Biologicals)    5.0 g 
Kellogg’s      10.0 ml 
 
GCP 
Protease Peptone #3 (Difco)    15.0 g 
Soluble Starch (Difco)    1.0g 
KH2PO4 (Sigma)     1.0g 
K2HPO4 (Sigma)     4.0g 
NaCl (US Biological)    5.0g 
HPLC H20 to 1 L 
 
Kellogg’s 
Glucose (Sigma)     400 g 
Glutamine (Sigma)     5.0 g 
Ferric nitrate (Sigma)     0.5 g 
Thiamine pyrophosphate   0.02 g 
HPLC H2O to 1 L 
 
LB Broth 
LB Broth Base (US Biological)   25.0 g 
HPLC H2O to 1L 
 
LB Agar 
LB Agar Base     40.0 g 
HPLC H2O to 1 L 
 
All media was sterilized by autoclaving except Kellogg’s which was filter-sterilized. 
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Table 2. Bacterial Strains used in these studies; all strains listed, except DH5-mcr, 
are Neisseria gonorrhoeae 
Strain name Description 
FA1090 Laboratory strain 
M1 FA1090 nfsB; G to T point mutation resulting in a premature stop 
codon at E168; Nitro resistant 
MS11 Laboratory strain 
F62 Laboratory strain 
FA19 Laboratory strain 
PID2 Laboratory strain 
nfsB G5 FA1090 altered nfsB sequence - ATGGGTGGGGGTACCGGT 
nfsB G6 FA1090 altered nfsB sequence - ATGGGGGGTACCGGT 
nfsB G7 FA1090 altered nfsB sequence - ATGGGGGGGACCGGT 
nfsB G8 FA1090 altered nfsB sequence - 
ATGGGTGGGGGGGGTACCGGT 
nfsB G9 FA1090 altered nfsB sequence - ATGGGGGGGGGTACCGGT 
nfsB G10 FA1090 altered nfsB sequence - ATGGGGGGGGGGACCGGT 
nfsB G12 FA1090 altered nfsB sequence - 
ATGGGGGGGGGGGGACCGGT 
E. coli DH5-mcr F-mcrA(mrr-hsdRMS-mcrBC)
endA1supE44thi-1recA1gyrA; relA1 (lacIZYA-argF) U169;  
deoR(89dlacD(lacZ)M15);  Source : BRL, Life Technologies 
Bold are additional nucleotides, and underline is the Poly-G tract. 
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Table 3.  Primers used in these studies 
Primer Name Primer Sequence 
NP1 AAAGGATCCCATGAACGCCATTGCAGACG 
NP2 GGGGGATCCAGAAGATACCATACGCCTCT 
S1 GAGATGGGTAAAATCCGGGT 
S2 CGAACCGGATGCCGTAGAA 
nfsBG-DGGE-F(gc) CGCCCGCCGCGCCCCGCGCCCGTCCCGCCGCCCCCGCC 
CGGAGATGGGTAAAATCCGGGT 
nfsBG-DGGE-R GCGGTTCTTGAATGCGGATAGAACCTGCTCTTTGCTTAA 
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Transformation of N. gonorrhoeae 
Piliated N. gonorrhoeae were incubated with plasmid DNA for 2-4 hours in GCP 
broth supplemented with 1mM MgCl2, 0.042% NaHCO3, and 1% Kellogg’s solution, in a 
rotary shaker at 37°C.  Various dilutions were plated onto GCK and GCK + 
spectinomycin (50 µg/mL) plates and incubated at 37°C for 24-48 hours.  Bacteria were 
transformed with plasmids prepared by Chris Holder in previous work and are listed in 
Table 4.
Transformation of E. coli 
 
Competent E. coli cells were prepared by the Inoue Method [70] and stored at -
80°C.  For transformation, competent cells were thawed on ice for 20 minutes, DNA was 
added, and the mixture was incubated for 10 minutes.  Cells were heat shocked at 37°C 
for 2 minutes.  To this 950 µl of LB broth was added, and cells were incubated at 37°C in 
a rotary shaker for 30-45 minutes.  Various dilutions were plated onto LB and LB-
antibiotic plates [70]. 
Crude Isolation of Gonococcal Chromosomal DNA 
 Chromosomal DNA was isolated from N. gonorrhoeae by suspending a small 
amount of bacteria in 5 µl of 0.5M NaOH.  This solution was neutralized by the addition 
of 5 µl of 1M Tris-HCl (pH 7.5).  The suspension was then diluted using 90 µl of purified 
water.  Prepared DNA could then be used to perform PCR.   
Agarose Gel Electrophoresis 
 
DNA fragments were separated using agarose gel electrophoresis using 1% 
agarose TBE gels.  DNA was visualized with Ethidium Bromide, which was added to the 
gel prior to pouring.  Gels were run at constant voltage of 90-100 volts for 45-75 minutes. 
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Table 4. Plasmids used in these studies 
Plasmid name Description 
pNFSB-polyG5 pK18, nfsB gene, unique AgeI site, V cassette, 5 guanine tract 
pNFSB-polyG6 pK18, nfsB gene, unique AgeI site, V cassette, 6 guanine tract 
pNFSB-polyG7 pK18, nfsB gene, unique AgeI site, V cassette, 7 guanine tract 
pNFSB-polyG8 pK18, nfsB gene, unique AgeI site, V cassette, 8 guanine tract 
pNFSB-polyG9 pK18, nfsB gene, unique AgeI site, V cassette, 9 guanine tract 
pNFSB-polyG10 pK18, nfsB gene, unique AgeI site, V cassette, 10 guanine tract 
pNFSB-polyG11 pK18, nfsB gene, unique AgeI site, V cassette, 11 guanine tract 
pNFSB-polyG12 pK18, nfsB gene, unique AgeI site, V cassette, 12 guanine tract 
NOTE: Plasmids were prepared by Chris Holder in previous work 
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Sequence Analysis 
 
The nfsB coding region was obtained from the N. gonorrhoeae sequenced genome 
found at the University of Oklahoma www.genome.ou.edu/gono.html. Verification of 
the gene’s function was done by a BLAST search, found at www.ncbi.nlm.nih.gov,
queried against the nfsB gene from E. coli. Other genes encoding proteins of similar 
function were found by BLAST and they were aligned using the ClustalW program from 
BCM Search Launcher (http://searchlauncher.bcm.tmc.edu/multi-align/multi-align.html).  
DNA Sequencing 
 
DNA sequencing was performed by Macrogen, Inc. in Seoul, Korea.  20 µl
samples of DNA, at a concentration of 50 ng/µl, were sequenced with primers at a 
concentration of 5 pmole/µl.  All nfsB sequences were obtained using primers S1 and S2. 
Minimum Inhibitory Concentration (MIC) 
 
The MIC of nitrofurantoin for N. gonorrhoeae was determined by plating cultures 
on various concentrations of nitrofurantoin in plated media.  Cultures of strain FA1090 
were suspended to a Klett = 100 (~5.0 x 108 CFU/mL), then plated onto GCK containing 
1, 2, 3, 4, and 5 µg/mL concentrations of nitrofurantoin.  Cultures were diluted and plated 
at 10-6 and 10-7 to assess spontaneous mutation frequency.  Colonies were counted 24-48 
hours after incubation and mutation frequency was calculated.  The MIC of nitrofurantoin 
is the lowest concentration that did not allow growth of the gonococcus.   
Verification of Poly-Guanine tract inserts 
 
N. gonorrhoeae containing the newly transformed poly-guanine tracts were 
verified using a three step process.  Cultures were re-streaked onto GCK + Spec (50 
µg/mL) to test for the insert of the Spec cassette and conferred antibiotic resistance.  
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Gonococcal DNA was isolated and the nfsB region was amplified by PCR with primers 
NP1 and NP2.  Products were examined for an increase in size over the wild-type 
FA1090 through 1% agarose gel electrophoresis.  PCR products of the appropriate size 
were cleaned up using QIAquick PCR Purification Kit (Qiagen).  These potential 
candidates were then digested with the restriction enzyme AgeI to verify the insertion of 
the novel restriction site at the beginning of the nfsB gene. 
Spontaneous Mutation Assay (SMA) 
 
Spontaneous mutation frequencies of gonococcal strains to a nitrofurantoin 
resistant (NitR) phenotype were detected using the following assay.  Overnight cultures 
were suspended to a Klett = 100 (~5.0 x 108 CFU/mL) and serial dilutions were made.  
100 µl aliquots of FA1090, MS11, F62, FA19, and PID2 were plated at 10-7 dilution onto 
GCK in duplicate to measure original CFU/mL and undiluted aliquots plated on GCK + 
Nitrofurantoin (3 µg/mL) in duplicate.  100 µl aliquots of all Poly-G variants of FA1090 
were plated on GCK at dilutions of 10-6 and 10-7 in duplicate.  Aliquots of nfsB G5 and 
nfsB G6 were plated at dilutions of 10-1 and 10-2 in duplicate onto GCK + Nitro (3 
µg/mL).  Aliquots of nfsB G8 and nfsB G9 were plated at dilutions of 10-2 and 10-3 in 
duplicate onto GCK + Nitro (3 µg/mL).   Aliquots of nfsB G7, nfsB G10 and nfsB G12 
were plated at dilutions of 10-3 and 10-4 in duplicate onto GCK + Nitro (3 µg/mL).  Plates 
were incubated for 24-48 hours, colonies were counted, and spontaneous mutation 
frequency was calculated (concentration of mutants/concentration of all bacteria).     
Nitroreductase Activity Assay (NAA) 
 
Bacteria were inoculated from freezer stocks onto GCK and GCK + Nitro (3 
µg/mL) to test for Nitro sensitivity.  After overnight incubation, the cultures were 
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suspended to a Klett = 100 and 1 mL was inoculated into 100 mL of GCP supplemented 
with 1 mL of 4.2% NaHCO3 and 1 mL of  Kellogg’s.  The GCP was incubated overnight 
in a shaker at 37°C.  Cells were collected by centrifugation for 10 minutes at 5,000 rpm 
with a Sorvall GSA rotor, and a pinkish pellet collected.  The supernatant was discarded 
and the cells were washed in 20 mL of filtered 1x PBS.  Cells were collected again by 
centrifugation for 10 minutes at 5,000 rpm with a Sorvall GSA rotor.  The supernatant 
was discarded and the pellet resuspended in 5 mL of 100 mM Tris-HCl, pH=7.5.  The 
suspension was transferred to a plastic tube and cells lysed by sonication (Branson 
Sonifier 250; 20% duty cycle, output control = 4; 45 seconds of sonication, followed by 
75 sec of cooling in ice, repeated twice for each sample.)  Lysed cellular material was 
collected by centrifugation at 10,000 rpm for 30 minutes in a Sorvall SS-34 rotor.  
Supernatant was transferred and the pellet discarded.  When performed, protein 
concentration in the lysate was measured using the BSA protein concentration assay and 
samples were adjusted to normalize protein concentration across all the samples.  800 µl
samples of the supernatant were added to 90 µl of water and placed in a quartz cuvette.  
The samples were blanked on an Ultraspec 2000 at a wavelength of 400nm.  
Nitrofurazone was added to the cuvette to a final concentration of 0.1 mM.  To start the 
reaction, NADPH was added to the cuvette to a final concentration of 0.2 mM.  Sample 
was mixed gently, then wavelength readings taken every 30 seconds for 10 minutes.  
BSA Protein Concentration Assay 
 
Assay was used to determine the protein concentrations of samples during 
Nitroreductase Activity Assay.  Samples were diluted 1:10 and 1:25 in triplicate.  Dye 
Reagent (Bio-Rad Protein Assay Dye Reagent Concentrate Catalog #500-0006) was 
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diluted 1:5 then filter sterilized before use.  10 µl of each sample was placed into separate 
wells on a 96-well plate.  BSA standards were added in duplicate at concentrations of 0, 
0.05, 0.1, 0.25, 0.4, 0.5 mg/mL.  200 µl of dye reagent was added to each well and 
incubated at room temperature for 5 to 60 minutes.  A plate reader was used to measure 
the wells at a wavelength of 595nm to determine protein concentration of the samples. 
 Denaturing Gradient Gel Electrophoresis (DGGE) 
 Adapted from a protocol by Wang, Watson, and Miller (11/4/04). 
 
DNA for DGGE was amplified using PCR with primers nfsBG-DGGE-F (gc) and 
nfsBG-DGGE-R to create a ~200 bp product with a 40-mer GC-clamp [71]. 
Amplification products were verified for proper band size and concentration by 
electrophoresis on a 1% agarose gel then purified using QIAquick PCR Purification Kit 
(Qiagen).  Poly-acrylamide gels were poured between two 20cm vertical glass plates 
using a gradient maker and 20 mL each of Denaturing Stock Solution A (0%) and 
Denaturing Stock Solution B (100%) for a 0-100% gradient gel.  TBE-saturated butanol 
was layered on top of the acrylamide gel immediately after pouring.  The acrylamide was 
allowed to polymerize for at least 2 hours.  The butanol layer was then removed and a 
comb inserted between the glass plates as not to disturb the acrylamide gel.  A stacking 
gel was poured using hot 0.7% agarose and allowed to solidify for 45 minutes.  The comb 
was removed and the gel was loaded into the buffer chamber with 1x TBE.  The gel 
contained a gradient ranging from 0% to 100% denaturant (100% denaturant being 7M 
Urea, 40% deionized formamide) or 40% to 100% denaturant.  DGGE was run at 
constant voltage (70 V) for 15 hours at 60°C unless otherwise stated. 
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Results
Identification of Nitroreductase genes in N. gonorrhoeae 
 
The complete genome of Neisseria gonorrhoeae strain FA1090 has been made 
available on the internet through the University of Oklahoma’s Advanced Center for 
Genome Technologies (www.genome.ou.edu/gono.html).  To detect potential 
nitroreductase genes in the genome of FA1090, the sequences of two E. coli 
nitroreductases, nfsA [64] and nfsB [65], were used to search for sequence similarity 
within the genomic DNA.  Although no significant sequence homology to nfsA was 
found, an open reading frame (ORF) with homology to nfsB was identified.  The 
gonococcal sequence, named ORF NGO0388 by the University of Oklahoma’s Advanced 
Center for Genome Technologies, has 25% identity and 42% homology with the E. coli 
NfsB protein (Figure 1). This gene will be defined as nfsB in for the remainder of this 
thesis.  The gonococcal amino acid sequence for NfsB was used to search through 
GenBank and find ORFs in other bacteria that possessed significant homology.  Figure 2 
shows the alignment of gonococcal NfsB with these homologs.  All of these proteins 
have nitroreductase activity and are found in a wide variety of bacteria.  Two major 
conserved regions are observed in the many nitroreductases including the hypothesized 
FMN-binding box near the N-terminus (residues 43-62) and another stretch of homology 
closer to the C-terminus (residues 148-171) with no identified function yet.  The 
beginning of these proteins show limited homology which suggests the N-terminus may 
be a good location to make modifications without disrupting conserved function. In 
creating a reporter system using this nitroreductase, the first few amino acids may be a 
good place to make the necessary modifications.    
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Figure 1 – NfsB BLAST Search of FA1090 Genome
Score = 62.0 bits (149), Expect = 2e-11
Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 16/228 (7%)
Frame = +2
Query: 3 IISVALKRHSTKAFDASKKLTPEQAEQIKTLLQYSPSSTNSQPWHFIVASTEEGKARVAK 62
++S R S + +DA++K++ E + I L + SPSS S+PW F+V E +
Sbjct: 381362 VLSAFKNRKSCRHYDAARKISAEDFQFILELGRLSPSSVGSEPWQFVVVQNPE-----IR 381526
Query: 63 SAAGNYVFNERKMLD-ASHVVVFCAKT--------AMDDVWLKLVVDQEDADGRFATPEA 113
A + + LD ASH+VVF AK ++ + + V + + + A +A
Sbjct: 381527 QAIKLFSWGMADALDTASHLVVFLAKKNARFDSPFMLESLKRRGVTEPDAVEKSLARYQA 381706
Query: 114 KAANDKGRKFFADMHRKDLHDDA---EWMAKQVYLNVGNFXXXXXXXXXXXXPIEGFDAA 170
A+D K L D +W +Q Y+ + N P+EGF+ A
Sbjct: 381707 FQADD----------IKILDDSRALFDWCCRQTYIALANMMTGAAMAGIDSCPVEGFNYA 381856
Query: 171 ----ILDAEFGLKEKGYTSLVVVPVGHHSVEDFNATLPKSRLPQNITL 214
+L +FGL + + V + V++ + K+R P T+
Sbjct: 381857 DMERVLSGQFGLFDAAEWGVSVAATFGYRVQEI---VTKARRPLEETV 381991
Fig. 1: TBLASTN results comparing E. coli NfsB (Ascension number = BAA35218) (Query) to N. gonorrhoeae FA1090 genome
(Subject). Only one sequence within the genome produced a significant alignment. The boxed region is the most conserved
region of the protein, which may include the FMN binding site [57].
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Fig. 2:  Nitroreductase Amino Acid Sequence Alignment.  GenBank was probed for 
nitroreductases in other microorganisms, particularly pathogens, using the 
FA1090 amino acid sequence of nfsB. The sequences were aligned using 
ClustalW.  Shaded regions show homology within the sequences with the 
consensus line (.=homology; *=identity) at the bottom of each row. 
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Figure 2 – Nitroreductase Amino Acid Sequence Alignment 
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Nitroreductase activity in N. gonorrhoeae 
 
If N. gonorrhoeae encodes a functional nitroreductase, the bacteria should be 
sensitive to nitro-aromatic antimicrobial agents, such as nitrofurantoin.  It should also be 
possible then to detect mutations that knock out the function of the nitroreductase by 
observing acquired resistance to nitrofurantoin.  These nitrofurantoin resistant (NitR)
mutants should lack measurable nitroreductase activity.  A spectrophotometric assay was 
performed to measure nitroreductase activity in N. gonorrhoeae. Samples contained cell 
lysates of FA1090 gonococcal culture mixed with nitrofurazone and the cofactor 
NADPH.  The samples were measured for a decrease in absorbance at 400 nm, which 
will detect declining concentration of nitrofurazone, hence nitroreductase activity [57].  
At first, samples were monitored at 340 nm to detect the conversion of the cofactor 
NADPH to NADP, which would be coupled with nitroreductase activity.  However, 
consumption of NADPH was observed in negative control samples that did not contain 
nitrofurazone.  Therefore, other proteins in the cell lysate may be using NADPH because 
these are crude lysates and not purified protein.  Hence the consumption of NADPH 
cannot be used as the true measure of nitroreductase activity.  The nitroreductase activity 
of FA1090 is shown in Figure 3, while the control of cell lysate with nitrofurazone 
(nitro) shows that without NADPH, there is no activity.  FA1090 possesses nitroreductase 
activity and has the ability to reduce nitrofurazone.  M1 is a spontaneous mutant resistant 
to nitrofuran antimicrobial agents characterized by Esteban Carrizosa.  The nitrofurantoin 
resistant M1 (FA1090nfsB) contains a single point mutation that inserts a premature 
stop codon at amino acid position 168, a glutamine, and a truncated protein is encoded.  
Carrizosa showed that M1 has no discernable nitroreductase activity indicating that a loss  
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Figure 3 – Nitroreductase Activity in FA1090 
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Fig. 3:  Nitroreductase Activity in N. gonorrhoeae strain FA1090.  Samples measured for 
a loss of absorbance at 400 nm, indicating a reduction of nitrofurazone by an 
active nitroreductase.  FA1090 (closed triangles, W) contains an active 
nitroreductase that requires the cofactor NADPH.  Without NADPH there is no 
activity, shown by the control containing lysate + nitrofurazone (star, *).  M1, an 
nfsB mutant of FA1090, does not have a functional nitroreductase and therefore 
cannot reduce nitrofurazone (closed circles, Y).  Samples measured every 30 sec 
for 10 min.  The data represents the average of 7 independent experiments.  Error 
bars were calculated using Standard Error of the Means.     
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of function mutation in nfsB will result in loss of nitroreductase activity and confer 
resistance to nitrofurans (unpublished work).  N. gonorrhoeae was found to possess a 
gene encoding a nitroreductase through searching the genome of FA1090 and showed 
nitroreductase activity.  E. coli possesses two nitroreductases that can reduce these nitro-
aromatic compounds; nfsA and nfsB, plus a nitroreductase activity that a gene encoding 
for the protein has yet to be determined [57, 61].  Therefore, it is possible that N. 
gonorrhoeae may possess another gene that confers nitroreductase activity.  In E. coli,
resistance to these nitro-aromatic antimicrobials occurs in a step-wise manner.  A 
mutation that knocks out the function of NfsA yields about three times more resistance, 
then a second mutation that knocks out the function of NfsB increases resistance to about 
10 times the wild-type [57].  Earlier attempts made by former lab members to isolate 
second-step mutants in N. gonorrhoeae plated isolates resistant to 3 µg/mL nitrofurantoin 
onto GCK plates containing 4, 6, 8, 16, and 32 µg/mL nitrofurantoin.  No secondary 
mutants were observed.  This suggests that the nfsB homolog found in ORF NGO0388 is 
the only nitroreductase in the gonococcus that is able to reduce nitro-aromatic 
compounds.  The existence of an additional nitroreductase would have resulted in the 
isolation of secondary mutants upon mutation in the second nitroreductase.  The absence 
of detectable nitroreductase activity in the mutant M1 supports this conclusion. 
 
MIC and Spontaneous Mutation Frequency Studies 
 Since N. gonorrhoeae possesses a nitroreductase, it should be sensitive to the 
nitro-aromatic antimicrobials, which are activated by the nitroreductase.  Therefore, it 
should be possible to isolate mutants that become resistant to these antimicrobials due to 
the loss of nitroreductase activity.  If nitrofurantoin or nitrofurazone can be used as a 
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selectable marker for N. gonorrhoeae then it would be possible to detect easily whether 
nfsB or the encoded protein is functional. This could lead to a reporter system with the 
nitroreductase being the gene/protein that is detected as being ON or OFF.  N. 
gonorrhoeae is sensitive to the nitro-aromatic antimicrobials and the minimum inhibitory 
concentration (MIC) of nitrofurantoin was determined to be 3 µg/mL (Table 5).  
 Spontaneous mutations occur in the gonococcal genome, and some of those will 
confer nitrofuran resistance because the mutation knocks-out the function of nfsB. If a 
reporter system is to be created based around this nitroreductase, it is important to know 
the spontaneous mutation frequency for nitrofurantoin resistance in gonococcal strains.  
The spontaneous mutation frequency of nitrofurantoin resistance was determined in five 
strains of N. gonorrhoeae, FA1090, F62, FA19, MS11, and PID2.  Gonococcal cultures 
were suspended to approximately 109 CFU/mL and serial dilutions were created.  The 
least dilute samples were aliquoted onto GCK plates supplemented with 3 µg/mL 
nitrofurantoin (to determine the frequency of nitrofurantoin resistant mutants that arise), 
while the most dilute samples were plated onto GCK to obtain viable cell counts.  The 
results are summarized in Figure 4 and Table 6. Spontaneous mutation frequencies 
ranged from 4.34x10-7 to 1.87x10-8; MS11 was the most mutable of all five strains, while 
FA1090 had the lowest spontaneous mutation frequency.   
 
Analysis and Manipulation of the nfsB coding region 
 In order to further study nfsB and to take steps to create a reporter system, the 
region had to be analyzed and modified.  To accomplish these goals, primers were 
created to amplify the nfsB coding region by polymerase chain reaction (PCR) and 
another set of primers was created to sequence the length of the coding region.  Primers 
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Table 5. MIC of Nitrofurantoin for FA1090 
 
Plates 10-6 10-7 1µg/mL 
2
µg/mL 
3
µg/mL 
4
µg/mL 
5
µg/mL
Avg. # of 
colonies 437 41 28 10 0 0 0 
CFU/mL 4.1 x 108 4.37 x 108 280 100 0 0 0 
Avg. = 4.24 x 108 - - MIC - -
Note: The average numbers of colonies counted on the specified plates are listed above.  
The MIC is the lowest concentration of nitrofurantoin that does not allow growth of the 
NitS FA1090.
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Figure 4 – Spontaneous Mutation Frequency of Gonococcal Strains to Nitrofurantoin 
 
Fig. 4: Spontaneous mutation frequency of various lab strains of N. gonorrhoeae is 
shown by the bar graphs.  Mutants that obtained nitrofurantoin resistance were 
counted from colonies arising on the GCK + Nitrofurantoin (3 µg/mL) plates after 
48 hours of incubation at 37ºC, 6% CO2. Data represent experiments done in 
triplicate.  The most mutable strain was MS11 with a mutation frequency of 
4.34x10-7±1.82x10-7; the least mutable was FA1090 with a frequency of 1.87x10-
8±1.53x10-8. Data values are shown in Table 6.  Error bars were calculated using 
Standard Error of the Means. 
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Table 6.  Spontaneous Mutation Frequencies for Nitrofurantoin Resistance 
 
N. gonorrhoeae 
strain 
Spontaneous Mutation 
Frequency 
FA1090 1.87x10-8  ± 1.53x10-8 
FA19 4.34x10-7 ± 1.82x10-7 
F62 5.16x10-8 ± 4.54x10-8 
MS11 6.76x10-8 ± 3.84x10-8 
PID2 2.48x10-7 ± 1.70x10-7 
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NP1 and NP2 (Table 3) were used to amplify the length of the coding region and create a 
PCR product roughly 2,400 base pairs (bp).  Primers S1 and S2 (Table 3) were designed 
to sequence the coding strand of the nfsB gene.  S1 sequences the first half of the gene, 
while S2 overlaps with the sequencing of S1 and sequences the second half of the gene.  
 In earlier work in the lab, Esteban Carrizosa and Chris Holder determined the 
DNA sequence of nfsB from five strains of N. gonorrhoeae, FA1090, FA19, MS11, F62, 
and PID2 (unpublished work), by sequencing the PCR products amplified from 
gonococcal chromosomal DNA using primers NP1 and NP2.  The sequence data 
indicated that all five strains contained identical sequences for nfsB. Since the DNA 
sequence and therefore the amino acid sequences are identical, the variability observed in 
spontaneous mutation frequency between these strains may be due to differences in DNA 
repair capabilities amongst these strains.   
 Earlier work in the lab done by Chris Holder and Esteban Carrizosa involved 
making subtle changes to the DNA sequence of nfsB to enhance its usage as a reporter 
system.  They isolated numerous nitrofurantoin resistant mutants and sequenced nfsB to 
locate the cause for the resistant mutant phenotype.  Missense, nonsense, single 
nucleotide transition, frame-shifting insertion and frame-shifting deletion mutations were 
all observed (unpublished work).  However, a majority of the frame-shifting mutations 
that were observed involved an insertion of one adenine base into a tract of five adenines.  
This suggested a bias for frame-shifting in this location and it was determined that this 
poly-A tract would need to be removed, while preserving the amino acid sequence, to 
clarify our observations in a future reporter system.  In previous work to remove the poly-
adenine tract, the nfsB gene was cloned into a plasmid (pK18) and modifications were 
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done using genetic tools in E. coli. With the poly-A tract changed, the resulting plasmid 
was transformed back into N. gonorrhoeae FA1090 using spot transformation [72] as to 
not insert a new selectable marker.  The subsequent change in the poly-A tract was 
verified by amplifying the nfsB gene by PCR and sequencing the DNA. 
 The goal was to create a reliable reporter system that could be used to directly 
measure phase variation, DNA repair, and/or frame-shifting events.  The gonococcal nfsB 
gene marks a good starting point for this reporter system, because it is known that we can 
measure activity of the nitroreductase by sensitivity or resistance to compounds like 
nitrofurantoin.  This can easily be observed on media that contains a nonpermissive level 
of nitrofurantoin and by growth of the gonococcus on this media.  Frame-shifting events 
in the bacteria could render the nfsB gene out-of-frame and the gonococcus would 
possess a nitrofurantoin resistant (NitR) phenotype.  The frequencies of this frame-
shifting could be assessed by determining the number of nitrofurantoin resistant colonies 
that arise from a nitrofurantoin-sensitive isolate.  Earlier research and studies in DNA 
repair and phase variation suggest that this could be accomplished by incorporating 
homopolymeric nucleotide tracts within the nfsB gene.  The first step to create such a 
reporter system was to create a gonococcal strain that possessed such a tract in the gene 
and then assess the gonococcal strain for viability and nitroreductase activity.  Poly-
guanine tracts play a major role in phase variation and frame-shifting.  There are many 
examples including pilC involved in pilin synthesis [22], another pili important gene pgtA 
[24], LOS biosynthesis genes lgtA, lgtC, lgtD [31, 32], and the hemoglobin receptors 
hpuA and hpuB [35], which undergo phase variation apparently due to poly-guanine 
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tracts.  Therefore, work was done in the lab to add a poly-guanine tract in the nfsB gene 
while maintaining the integrity of the gene and the encoded protein. 
 Again the nfsB coding region was amplified using primers NP1 and NP2, the gene 
was cloned into pK18, and transformed into E. coli strain DH5MCR (Table 2).  
Manipulations to the gene were done by Chris Holder in the E. coli background using 
various primers to add poly-guanine tracts to nfsB in varying lengths from 5 guanines to 
12 guanines, but the nfsB gene remained in frame in all cases with the addition of extra 
guanines and thymines.  All strains with poly-guanines consecutively after the start codon 
would still be able to encode a functional nitroreductase.  Amino acid sequence 
alignments of nitroreductases suggested that the first few amino acids of NfsB could be 
modified without effecting changes in protein function (Figure 2); [57].  The process of 
adding the poly-guanine tracts also incorporated a novel AgeI restriction site.  To select 
for transformation of the new nfsB gene into the gonococcal chromosome, a V fragment 
that confers spectinomycin resistance (Specr) was added 86 bp downstream from the stop 
codon of the nfsB sequence.  The plasmids were extracted from spectinomycin resistant 
transformants of E. coli and the isolated plasmids (Table 4) were ready to be transformed 
into N. gonorrhoeae FA1090.    
 
Transformation/Verification of Poly-guanine tract nfsB variants 
 The modified versions of the nfsB coding sequence were introduced into the 
gonococcal genome by transformation.  Piliated FA1090 cells were suspended in GCP 
broth and the appropriate plasmid was added.  Cells were incubated for 4 hours in a 
rotary shaker at 37°C.  After incubation, aliquots were plated on GCK agar that contained 
50 µg/mL spectinomycin to select for the modified nfsB gene.  Transformants were 
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detected after 36-48 hours of incubation at 37°C, 6% CO2. Separate transformations 
were done for each poly-guanine length.  Various outcomes may have occurred from the 
transformation that led to the isolated transformant to be selected.  Possible outcomes like 
the Spec cassette inserting into the chromosome alone had to be ruled out and verification 
that the desired transformation occurred needed to be obtained.   
 There were three steps to verify the modified nfsB gene inserted into the 
gonococcal chromosome.  Taken together, these steps verify transformation of FA1090 
with a new nitroreductase gene that includes poly-guanine tracts.  Figure 5 is a schematic 
illustration of the coding region of nfsB in both wild-type (wt) FA1090 and the Poly-G 
variants after the targeted manipulations.  Represented here are the three steps needed for 
verification.  The Poly G variants include a cassette that confers spectinomycin resistance 
just downstream of the nfsB stop codon that makes the Poly-G variants Specr while 
FA1090 (wt) remains spectinomycin sensitive (SpecS).  Also this increases the size of the 
PCR product from primers NP1 and NP2 from 2.4kB to 4.4kB, which can be viewed 
through gel electrophoresis.  Finally, a novel AgeI restriction digest site can be observed 
in the PCR products of the Poly-G variants. 
 Step one of verification was rather simple.  The selected strains to test for Poly-G 
insertion in nfsB were streaked onto GCK plates containing 50 µg/mL spectinomycin.  
The original FA1090 (wt) was also inoculated onto GCK + Spec as a negative control for 
growth.  Chromosomal DNA was isolated from the isolates that grew on GCK + Spec 
plates.  For step two, the nfsB coding region was PCR amplified with primers NP1 and 
NP2 from the gonococcal chromosomal DNA.  The PCR products for each isolate and 
FA1090 (wt) were run on a 1% agarose gel for 60 min at 100V to separate based on size  
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Figure 5 – Schematic of the new nfsB Coding Region 
 
Fig. 5:  Schematic illustration comparing the newly modified nfsB coding region and the 
original coding region. Sizes are representative of PCR products produced from 
primers NP1 and NP2.  Smaller sizes listed for the modified coding region are 
indicative after AgeI digestion.  The modified coding region is ~2 kB larger due 
to an inserted Specr (V) cassette and contains a novel AgeI restriction digest site.  
Finally the new nfsB coding region contains the appropriate length poly-guanine 
tract. 
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of the fragments.  Poly-G variants are selected based on a shift in band size (~4.4kB) 
therefore these PCR products do not run as far through the agarose gel.  Lambda-DNA 
ladder () is added to the gel to determine size of bands based on known band sizes.  
Many isolates were screened in this study but in the end, one Poly-G variant was chosen 
for each desired poly-guanine tract length, ranging from 5 guanines to 12.  The 
appropriate band sizes and mobility shifts in agarose gel electrophoresis for these variants 
can be observed in Figure 6 (lanes 3-8).  Isolating a positive variant for a guanine tract 
of 9 was not as simple, but will be discussed later.  Step three checks for the AgeI 
restriction digest site using the PCR products from each potential variant.  PCR products 
were purified using QIAquick PCR Purification Kit (Qiagen).  The DNA was digested 
using the restriction enzymes AgeI for 4 hours, and then run on a 1% agarose gel to 
determine restriction patterns.  Unmodified FA1090 (wt) does not contain an AgeI site 
and therefore is not cut (Figure 7, lane 3).  Modified Poly-G variants that are selected for 
contain one AgeI restriction site near the poly-guanine tract.  The appropriate sizes of the 
two bands observed after digestion are ~0.9kB and ~3.5kB (Figure 7, Figure 5)
One isolate was chosen for each desired length of poly-guanine tract in the nfsB 
gene.  These strains were named Poly-G variants of FA1090 and individually named nfsB 
Gx, where x is the length of the poly-guanine tract found in nfsB (Table 2).  No isolates 
for poly-guanine tract length of 9 passed all three steps of the verification process using 
the purified plasmids for transformation prepared by Chris Holder. For guanine tracts of 
9 nucleotides, the plasmids had to be re-isolated and then retransformed into FA1090 
numerous times.  Some isolates grown onto GCK + Spec after transformation possessed 
the desired size of the nfsB region, but did not contain the novel AgeI restriction site  
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Figure 6 – PCR amplification of nfsB coding regions in Poly-G Variants 
 
Fig. 6:  The nfsB coding regions of both FA1090 wild-type and the Poly-G inserted nfsB 
variants were amplified with primers NP1 and NP2.  Products run on a 1% 
agarose gel for 60 min at 100V.  Numbers to the left represent sizes of bands of 
the Lambda () DNA ladder in base pairs. FA1090 without poly-G insert is 
smaller (~2.4kB), while variants with Poly-G insert contain the Spec resistance 
(V) cassette and are bigger products (~4.4kB).  G5 = strain nfsB G5; G6 = strain 
nfsB G6; G7 = strain nfsB G7; G8 = strain nfsB G8; G10 = strain nfsB G10; G12 = 
strain nfsB G12; 
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Figure 7 – AgeI Restriction Digest of nfsB 
 
Fig. 7:  Amplified PCR products were digested with restriction enzyme AgeI for 4 hours.  
Samples were run side by side with a sample where AgeI was not added, 
indicated by the (-) sign.  AgeI digested samples are indicated by a (+) sign above 
the lane.  Products were run on a 1% agarose gel for 60 min at 100V.  Insertion of 
the poly-guanine tracts also inserted a novel AgeI restriction site.  2 bands are 
observed after digestion; ~0.9kB and ~3.5kB.  FA1090 (wt) does not contain an 
AgeI restriction site therefore only one band is observed.  Numbers to the left 
represent sizes of bands of the Lambda () DNA ladder in base pairs. Poly G5 = 
strain nfsB G5; Poly G6 = strain nfsB G6; Poly G7 = strain nfsB G7; Poly G8 = 
strain nfsB G8; Poly G10 = strain nfsB G10; Poly G12 = strain nfsB G12; 
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(Figure 8).  Figure 8 shows a very small sample size, illustrating a Poly-G9 transformant 
that did not digest with AgeI and one transformant that did digest.  This transformant was 
the isolate chosen as the Poly-G variant with a tract of 9 guanines.   
After obtaining viable, verified transformants for each desired length of guanine 
tract, an isolate for each variant was stored as a freezer stock in -80°C.  To further verify 
the presence of the poly-guanine tracts in the nfsB gene and to assure other areas of the 
sequence were kept unchanged, the DNA of the variants and the wild-type (unmodified 
FA1090) were analyzed.  PCR products were amplified from gonococcal chromosomal 
DNA using primers NP1 and NP2.  These DNAs were then purified using a Qiagen kit 
and 20 µl samples were sent to Macrogen, Inc. in Seoul, Korea for sequencing of the nfsB 
region using primers S1 and S2 (Table 3).  M1, the nfsB mutant, was also sent for 
sequencing.  The nfsB sequences of M1 and FA1090 were aligned using ClustalW 
(Figure 9).  The M1 sequence was identical to the parent except for a single nucleotide 
change, a G changed to a T, which creates a premature stop codon (TAA) within nfsB for 
M1.  The sequences of all the Poly-G variants and FA1090 were aligned using ClustalW 
(Figure 10).  The sequences were virtually identical.  The inserted AgeI restriction site 
(ACCGGT) can be observed in every Poly-G variant, changed from ACAGTA in 
FA1090.  The proper length of guanine tract can be observed in each variant while the 
coding sequence remains in frame.  The sequences returned from Macrogen, Inc, and 
viewed in Figure 10 are from the first samples sent of these variants, and the sequences 
of the Poly-G regions were as predicted.   
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Figure 8 – Selection of nfsB G9 Variant 
 
Fig. 8:  The proper transformation to obtain the nfsB G9 variant was harder to obtain than 
the others. Here Lanes 2 and 3 represent one of the many nfsB G9 transformants 
that did not digest properly with AgeI.  Lanes 4 and 5 represent the nfsB G9 
variant chosen to continue the work.  It digested with AgeI to form 2 bands 
representative of the insertion of the novel AgeI site and the poly-guanine tract.  
PCR products were digested with AgeI (+) or not digested (-).  Numbers to the 
left represent sizes of bands of the Lambda () DNA ladder in base pairs. G9 = 
strain nfsB G9.  
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Fig. 9:  The coding region of the nfsB gene in both FA1090 (wt) and M1 (NitR mutant) 
were amplified with primers NP1 and NP2.  Products were purified using the 
QIAquick PCR Purification Kit (Qiagen).  PCR products were sent to Macrogen, 
Inc. (Seoul, Korea) to be sequenced.  Sequences were aligned using ClustalW.  
Note the start and stop codons of the nfsB gene and the single point mutation (G 
to T) that creates a premature stop codon making M1’s encoded nitroreductase 
non-functional. 
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Figure 9 – nfsB Sequence Alignment of FA1090 and M1 (NitR mutant) 
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Fig. 10: The coding region of the nfsB gene in FA1090 (wt) and the Poly-G variants were amplified with primers NP1 and NP2.
Products were purified and sequenced. Sequences were aligned using ClustalW. Note the inserted poly-guanine tracts of
specified length following the ATG in the Poly-G variants and the novel AgeI restriction site (ACCGGT). G5 = strain nfsB
G5; G6 = strain nfsB G6; G7 = strain nfsB G7; G8 = strain nfsB G8; G9 = strain nfsB G9; G10 = strain nfsB G10; G12 =
strain nfsB G12. Consecutive guanines in the poly-guanine track are shown in BOLD. Additional nucleotides inserted into
the nfsB gene, including base pairs added to keep the gene in frame, are shown inside the black box. Start and Stop codons
are marked as is the AgeI restriction site.
Figure 10 – NfsB Sequence Alignment of FA1090 and Poly-G Variants
START AGEI site
FA1090 1 GAAATCAATTTGCAATCAAAGTAATAAAAGGATGCACGATG------------ACAGTAT
G5 1 GAAATCAATTTGCAATCAAAGTAATAAAAGGATGCACGATGGGTGGGG---GTACCGGTT
G6 1 GAAATCAATTTGCAATCAAAGTAATAAAAGGATGCACGATGGG-GGG-----TACCGGTT
G7 1 GAAATCAATTTGCAATCAAAGTAATAAAAGGATGCACGATGGGGGGG------ACCGGTT
G8 1 GAAATCAATTTGCAATCAAAGTAATAAAAGGATGCACGATGGGTGGGGGGGGTACCGGTT
G9 1 GAAATCAATTTGCAATCAAAGTAATAAAAGGATGCACGATGGGGGGGG---GTACCGGTT
G10 1 GAAATCAATTTGCAATCAAAGTAA-AAAGGGATGCACGATGGGGGGGG---GGACCGGTT
G12 1 GAAATCAATTTGCAATCAAAGTAATAAAAGGATGCACGATGGGGGGGGGGGGTACCGGTT
consensus 1 ************************.***.************....... ..**.*..*
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Nitroreductase Activity of Poly-G Variants 
After confirmation that the correct poly-guanine lengths were inserted properly 
into the nitroreductase gene for each Poly-G variant of FA1090, the nitroreductase 
activity was analyzed.  If the variant does not encode a nitroreductase that has activity in 
reducing nitrofuran antimicrobials, it will not be useful for a reporter system.  The 
activity of the enzyme was tested by measuring the loss of absorbance at 400 nm using a 
spectrophotometer.  At 400 nm, a loss of absorbance in these studies is the reduction of 
nitrofurazone in the sample lysates.   
The procedure used for the Nitroreductase Activity Assay (NAA) was developed 
in the lab and then further refined throughout the process of collecting data and 
suggestions from a paper by Whiteway et al. (1998) [57].  Strains of N. gonorrhoeae 
were streaked onto GCK and GCK + Nitrofurantoin (3 µg/mL) to test for nitrofuran 
sensitivity at the onset of the experiment.  Strains were passaged directly from freezer 
stocks every time to limit mutation of the poly-guanine tract.  Then to help minimize 
differences in cell culture size, the strains were suspended in 4 mL of GCP to a Klett = 
100 (roughly 109 CFU/mL).  1 mL of the suspended culture was added to 100 mL of GCP 
supplemented with 1 mL of 4.2% NaHCO3 and 1 mL of Kellogg’s.  This was incubated 
overnight in a shaker at 37°C.  The next day, the cultures were centrifuged and washed to 
collect a pinkish-colored pellet.  The pellet of bacteria was resuspended in Tris-HCl 
(pH=7.5) and sonicated to lyse the cells and release the cell contents into solution.  This 
will release the nitroreductase encoded by that strain into the sample solution so it can be 
tested for activity.  The samples were centrifuged further and the supernatant collected 
with the cell’s inner contents including protein suspended in the supernatant.  Each 
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sample was tested one at a time in a quartz cuvette.   800 µl of supernatant (cell lysate) 
was added to the cuvette with 90 µl of dH2O.  The cuvette was then placed in the 
spectrophotometer and the sample was blanked at this time to eliminate any background 
reading or slight differences between cell lysates.  Next, nitrofurazone was added to the 
cuvette to a final concentration of 0.1 mM.  To start the reaction, NADPH was added to 
the cuvette to a final concentration of 0.2 mM.  The samples were mixed gently and 
readings of absorbance taken every 30 seconds for 10 minutes.  Originally readings were 
taken every 20 seconds for 2 minutes, but it was observed that some of these variant 
strains had a reduced nitroreductase activity which was better analyzed over a ten minute 
assay.  The controls used for each poly-guanine length were samples of FA1090 and M1.  
These had full activity and no activity, respectively (Figure 3).  Also, a sample of cell 
lysate and only nitrofurazone was observed to maintain that NADPH was required and to 
show that there was no nitrofuran reduction without it.  Each Poly-G variant was tested 
alongside a nitrofuran resistant mutant isolated from that variant strain.  This mutant is 
expected to have little to no activity like the M1 mutant.  In the figures for the 
nitroreductase activity, the circles (Y, \) are the nitrofuran resistant mutants; the triangles 
(W, ]) are nitrofuran sensitive strains.  The filled data points (Y,W) are for the Poly-G 
variant being tested and the open data points (\, ]) are controls.  All data is 
representative of experiments done in triplicate.   
The variant nfsB G5 has nitroreductase activity that reduces the amount of 
nitrofurazone over the 10 minute sample, but the reduction is not as fast as that observed 
with FA1090 lysates (Figure 11).  The absorbance for FA1090 levels off around 100 
seconds in most experiments and does not appear to further reduce nitrofurazone after  
55
Figure 11 – Nitroreductase Activity of nfsB G5 
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Fig. 11: The Nitroreductase activity of variant strain nfsB G5 was tested with the 
reduction of nitrofurazone at 400nm.  nfsB G5 (W, closed triangles) had activity 
in reducing nitrofurans but not as much as the wild-type FA1090 (], open 
triangles).  A NitR mutant of nfsB G5, called nfsB G5-NrA (Y, closed circles) 
showed no activity just like M1 (\, open circles).  No activity is observed 
without the co-factor NADPH (*, stars).  The data is from experiments done in 
triplicate, errors bars calculated from Standard Error of the Means (SEM).   
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that, which could represent the complete conversion of the nitrofurazone or the assay mix 
runs out of NADPH.  The reduction by FA1090 is faster than the Poly-G variants but 
nfsB G5 possesses distinguishable activity from both M1 and its NitR-counterpart.  Like 
nfsB G5, nfsB G6 has activity distinguishable from M1 and its NitR-mutant but the 
activity falls somewhere between the mutants and the sensitive control (Figure 12).  
Variant nfsB G7 possessed nitroreductase activity that mimicked the wild-type FA1090 
(Figure 13).  The activity was the best of all the variants and was closest to the wild-type 
strain before adding poly-guanine tracts, while the mutant of nfsB G7 did not possess any 
activity.  Variant nfsB G8 possessed reduced nitroreductase activity but was still 
discernable from both M1 and the nfsB G8 mutant (Figure 14).  nfsB G8 reduces 
nitrofurazone but at a much slower rate than nfsB G7, nfsB G5, and nfsB G6.  Poly-G 
variant nfsB G9 possessed activity relatively similar to nfsB G5 and nfsB G6, while 
reducing the nitrofurans slower than the wild-type FA1090 (Figure 15).  Variants with 
poly-guanine tracts of lengths 5, 6, and 9 may eventually reach an absorbance level as 
low as FA1090 given more time.  It appears that these variants are slower in reducing 
nitrofurans than the wild-type FA0190, but still possess activity.  Variants nfsB G10 
(Figure 16) and nfsB G12 (Figure 17) both have very little nitroreductase activity and 
the drop in absorbance observed is barely distinguishable from the NitR mutants.  Both of 
these variants appear to have lost most of their activity by the insertion of these longer 
poly-guanine tracts or the long tracts creates a higher frequency of nitrofuran resistant 
mutants and the activity observed is diluted.   
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Figure 12 – Nitroreductase Activity of nfsB G6 
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Fig. 12: The Nitroreductase activity of variant strain nfsB G6 was tested with the 
reduction of nitrofurazone at 400nm.  nfsB G6 (W, closed triangles) had activity 
in reducing nitrofurans but not as much as the wild-type FA1090 (], open 
triangles).  A NitR mutant of nfsB G6, called nfsB G6-NrA (Y, closed circles) 
showed no activity just like M1 (\, open circles).  No activity is observed 
without the co-factor NADPH (*, stars).  The data is from experiments done in 
triplicate, errors bars calculated from Standard Error of the Means (SEM).   
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Figure 13 – Nitroreductase Activity of nfsB G7 
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Fig. 13: The Nitroreductase activity of variant strain nfsB G7 was tested with the 
reduction of nitrofurazone at 400nm.  nfsB G7 (W, closed triangles) had activity 
in reducing nitrofurans close to the wild-type FA1090 (], open triangles).  A NitR
mutant of nfsB G7, called nfsB G7-NrA (Y, closed circles) showed no activity just 
like M1 (\, open circles).  No activity is observed without the co-factor NADPH 
(*, stars).  The data is from experiments done in triplicate, errors bars calculated 
from Standard Error of the Means (SEM).   
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Figure 14 – Nitroreductase Activity of nfsB G8 
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Fig. 14: The Nitroreductase activity of variant strain nfsB G8 was tested with the 
reduction of nitrofurazone at 400nm.  nfsB G8 (W, closed triangles) had activity 
in reducing nitrofurans but small activity when compared to the wild-type 
FA1090 (], open triangles).  A NitR mutant of nfsB G8, called nfsB G8-NrA (Y,
closed circles) showed no activity just like M1 (\, open circles).  No activity is 
observed without the co-factor NADPH (*, stars).  The data is from experiments 
done in triplicate, errors bars calculated from Standard Error of the Means (SEM).   
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Figure 15 – Nitroreductase Activity of nfsB G9 
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Fig. 15: The Nitroreductase activity of variant strain nfsB G9 was tested with the 
reduction of nitrofurazone at 400nm.  nfsB G9 (W, closed triangles) had activity 
in reducing nitrofurans but not as much as the wild-type FA1090 (], open 
triangles).  A NitR mutant of nfsB G9, called nfsB G9-NrA (Y, closed circles) 
showed no activity just like M1 (\, open circles).  No activity is observed 
without the co-factor NADPH (*, stars).  The data is from experiments done in 
triplicate, errors bars calculated from Standard Error of the Means (SEM).   
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Figure 16 – Nitroreductase Activity of nfsB G10 
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Fig. 16: The Nitroreductase activity of variant strain nfsB G10 was tested with the 
reduction of nitrofurazone at 400nm.  nfsB G10 (W, closed triangles) had activity 
in reducing nitrofurans but small activity when compared to the wild-type 
FA1090 (], open triangles).  A NitR mutant of nfsB G10, called nfsB G10-NrA (Y,
closed circles) showed no activity just like M1 (\, open circles).  No activity is 
observed without the co-factor NADPH (*, stars).  The data is from experiments 
done in triplicate, errors bars calculated from Standard Error of the Means (SEM).   
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Figure 17 – Nitroreductase Activity of nfsB G12 
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Fig. 17: The Nitroreductase activity of variant strain nfsB G12 was tested with the 
reduction of nitrofurazone at 400nm.  nfsB G12 (W, closed triangles) had activity 
in reducing nitrofurans but small activity when compared to the wild-type 
FA1090 (], open triangles).  A NitR mutant of nfsB G12, called nfsB G12-NrA (Y,
closed circles) showed no activity just like M1 (\, open circles).  No activity is 
observed without the co-factor NADPH (*, stars).  The data is from experiments 
done in triplicate, errors bars calculated from Standard Error of the Means (SEM).   
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Nitroreductase activity of nfsB G7 resembles FA1090, while nfsB G5, nfsB G6, and nfsB 
G9 are less than nfsB G7.  nfsB G8 activity is less than those variants, while more than 
both nfsB G10 and nfsB G12. 
The differences observed in nitroreductase activities among the poly-G variants 
may have been due to the amount of protein found in each sample, which can be 
impossible to control for cells lysed by sonication given currently available experimental 
tools.  In the future, antibodies may be available for NfsB and the protein and be properly 
purified and quantified.  Furthermore, it is possible that in the process of releasing 
proteins by sonication, some of the protein may be irreversibly denatured.  If a sample 
contained more bacteria, the cell lysate would contain more protein and more expressed 
nitroreductase.  The Poly-G variants were tested together striving to keep the conditions 
equivalent.  Bio-Rad protein assay was used to determine the protein concentration in the 
cell lysates, and then the lysates were normalized for concentration of protein.  This assay 
will determine general amounts of protein to help show that variation observed in 
previous NAA are not due to large differences in sample size or conditions, such as a 
change in CFU/mL.  This assay will not tell us anything about the specific expression 
level of nitroreductase in each variant, but can rule out differences in sample size or 
environmental conditions.  The normalized cell lysates were tested using NAA protocol 
and activity observed (Figure 18).  The activities of the variants were similar to those 
observed in the individual assays.  
 
Spontaneous Mutation Frequency of Poly-G Variants 
 It was important to know the spontaneous mutation frequency of the 
nitroreductase to a nitrofuran resistant state after addition of poly-guanine tracts.  It was  
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Fig. 18:  The nitroreductase activities of all the Poly-G variants were tested 
simultaneously while the protein concentration was normalized to the wild-type 
FA1090.  The experiment hoped to rule out environmental factors and 
difference in bacterial concentration.  Protein concentration was determined 
using BSA protein concentration assay.  The table shows mean protein 
concentrations and the fold differential from the wild-type detected in each 
sample.  The samples were normalized to FA1090 protein concentration, so all 
samples would have the same concentration of protein present.  Activities are 
shown by a decrease in absorbance at 400 nm, meaning nitrofurans are being 
reduced.  Data is shown in the graph for decrease in absorbance over time at 
400 nm.     
 
65
Figure 18 – Nitroreductase Activity of Poly-G Variants with Protein Normalization 
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FA1090 2.57 1.0 
nfsB G5 3.17 1.2 
nfsB G6 3.45 1.3 
nfsB G7 4.29 1.7 
nfsB G8 3.78 1.5 
nfsB G9 4.98 1.9 
nfsB G10 3.07 1.2 
nfsB G12 6.01 2.3 
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hypothesized that more mutants would be observed as the length of guanines increased 
due to slipped-strand mispairing during replication.  The function of the reporter system 
relies on knowing the spontaneous mutation frequency to our selectable agent before 
work can begin.  The mutation frequency was determined by exposing the strains to 
nitrofurantoin and measuring the survival of mutants that are now NitR. Unmutated 
bacteria will die as a result of reducing nitrofurantoin.  A suspension of bacteria (~109
CFU/mL or Klett = 100) was serially diluted and plated on selective and non-selective 
GCK plates.  The most concentrated serial dilution samples were plated onto GCK + 
nitrofurantoin (3 µg/mL).  The least concentrated dilutions were plated onto GCK.  After 
48 hours of incubation, colonies were counted.  Colonies on the plates with nitrofurantoin 
were used to calculate mutants/mL and colonies on GCK were used to calculate original 
CFU/mL of the sample.  It was possible to determine mutation frequency using these 
concentrations (Figure 19). 
 It was thought that the largest increase in mutation frequency would be seen 
where poly-guanine lengths reached 10, this length seems to be associated with efficient 
LOS phase variation.  However, it appears that the rate increases beginning with lengths 
around 5, 6, and 7.  The minimum length of poly-guanine tracts that is important for 
increased slipped-strand mispairing is shorter than first hypothesized.  The mutation 
frequency increases 5 to 10 fold from FA1090 (~1.28x10-7) to nfsB G5 (~6.24x10-7) to 
nfsB G6 (~1.22x10-5) and to nfsB G7 (~5.18x10-4).    The increase in mutation frequency 
levels off in poly-guanine lengths over 8 between 10-4 and 10-5. The mutation 
frequencies of nfsB G8, nfsB G9, nfsB G10, and nfsB G12 observed were ~4.36x10-5,
~6.32x10-5, ~2.27x10-4, and ~4.85x10-4, respectively.  Spontaneous mutation frequencies  
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Figure 19 – Spontaneous Mutation Frequency of Poly-G Variants 
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Fig. 19: The spontaneous mutation frequencies of the strains were tested as the 
frequency of mutation from a NitS phenotype to a NitR phenotype in the presence 
of 3 µg/mL nitrofurantoin.  The longer the length of poly-guanines in the 
nitroreductase the more likely the strain is to obtain a mutation conferring 
resistance.  Each data set is from at least 3 experiments.  The actual values are 
listed in Table 7.  Error bars were calculated using Standard Error of the Means. 
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Table 7 – Mutation Frequencies for Poly-Guanine Strains 
N. gonorrhoeae 
strain 
Spontaneous Mutation 
Frequency 
FA1090 1.28x10-7 ± 3.94x10-8 
nfsB G5 6.24x10-7 ± 3.14x10-7 
nfsB G6 1.22x10-5 ± 1.11x10-5 
nfsB G7 5.18x10-4 ± 5.08x10-4 
nfsB G8 4.36x10-5 ± 1.65x10-5 
nfsB G9 6.32x10-5 ± 2.81x10-5 
nfsB G10 2.27x10-4 ± 6.65x10-5 
nfsB G12 4.85x10-4 ± 9.06x10-5 
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were calculated from data including at least three separate experiments for every poly-G 
strain.  Table 7 contains the frequencies and Figure 19 is a bar-graph representation of 
the increase in mutation frequency due to poly-guanine tract length increase.  The data 
suggest there is a relationship between poly-guanine tract length and increased mutation 
frequency.  Lengths as short as 5 consecutive guanines can cause increased mutation. 
 
Detection of Frame-shifting by Denaturing Gradient Gel Electrophoresis 
 The next step in the project was to determine the genetic basis for the phenotype 
switch that is observed in the Poly-G strains.  Many NitR mutants were obtained and 
isolated from calculating spontaneous mutation frequency.  It was hypothesized that 
many contain mutations in the poly-guanine tract with an addition or deletion of a 
nucleotide that would cause a frame-shift.  This could prevent expression of a functional 
nitroreductase.  Other mutant phenotypes may be due to mutations in different areas of 
the nfsB gene.  A method was sought that could be used to easily detect frame-shifting 
insertions or deletions prompting a NitR phenotype.  The general approach was to amplify 
the nfsB region from the NitR mutants and their parent cells and compare amplicon 
fragment sizes.  The expectation was that fragments from NitR mutants would be 1 to 2 
base pairs larger or smaller due to extra guanine insertion or deletion viewed by 
electrophoresis.   
 To accomplish the best resolution between single base pair differences, samples 
would be run on poly-acrylamide gels and a GC-clamp would be attached [71].  The GC-
clamp would be added using select PCR primers.  An area approximately 150 bp would 
be amplified that includes the poly-guanine tract.  The primers were specifically designed 
to add a 40-mer of guanines and cytosines to one end of the PCR product.  The GC-clamp 
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is added by primer nfsBG-DGGE-F (gc) (Table 3) to the 5’ end in respect to the nfsB 
gene.  The other primer, nfsBG-DGGE-R (Table 3), positions the poly-guanine tract near 
the 3’ end of the PCR product in respect to the gene.  This places the GC-clamp and the 
poly-guanine tract at opposite ends of the small ~200 bp fragment.  A procedure known 
as denaturing gradient gel electrophoresis (DGGE) combines the use of the GC-clamp 
with a linear gradient of urea and formamide created when pouring the poly-acrylamide 
gel.  Urea and formamide when combined with high temperature (60°C) form a linear 
denaturing gradient that increases from top to bottom in the gel.  In most cases the top of 
the gel, near the loading chambers for samples is 0% denaturant (no urea or formamide), 
and the bottom of the gel is 100% denaturant.  100% denaturant solution contains 42% 
urea and 40% formamide.  DNA samples run in this gradient will denature from double-
stranded to single-stranded will traversing down the gel.  The amount of denaturant that 
is required to denature a given piece of DNA is dependant on the nucleotide make-up of a 
DNA sample.  For example, higher concentration of denaturants is needed for DNA with 
a higher Tm value.  Long stretches of guanines and/or cytosines have a higher Tm value 
and will take a higher concentration of urea and formamide to denature.  Therefore, a 
DNA sample will denature at a certain point in the gel when it reaches the minimal 
concentration of denaturant required in the linear gradient. The GC-clamp was designed 
so that it will not be denatured.  The other nucleotides in the PCR products used here 
denature but the GC-clamp remains double-stranded, so the DNA acts like a long single-
stranded piece of DNA in the gel.  Because it acts like a long-single-stranded piece of 
DNA it will run slower through the gel.  Samples with a poly-guanine tract will not 
denature as quickly in the gel.  In these samples, both ends of the PCR product will 
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remain double-stranded longer and therefore travel farther in the gel.  The more guanines 
present in the tract, the harder to denature, so the farther a fragment will run in the gel 
before behaving as a long single-stranded DNA.  For example, DNA with a tract of 10 
guanines will run farther in the gel than DNA with a tract of 5 guanines.  Both of these 
fragments would run farther than DNA without a poly-guanine tract (Figure 20).          
 The Poly G variants and FA1090 DNA were amplified using the specified primers 
and the products were run on a DGGE gel.  The sizes of the fragments vary due to added 
guanines and other nucleotides added to keep some guanine tracts in frame.  The 
sequences are shown in Figure 10 and the sizes are as follows: FA1090 – 197 bp, nfsB 
G5 – 206 bp, nfsB G6 – 203 bp, nfsB G7 – 203 bp, nfsB G8 – 209 bp, nfsB G9 – 206 bp, 
nfsB G10 – 206 bp, nfsB G12 – 209 bp.  The poly-acrylamide gel was poured to create a 
gradient ranging from 0% denaturant solution at the top of the gel to 100% denaturant 
solution (42% urea, 40% formamide) at the bottom of the gel.  After a minimum of 2 
hours of polymerization, a comb was inserted and a 0.7% agarose stacking gel was 
poured.  After an hour of solidification, the comb was removed and lanes washed with 
1xTBE.  Samples were loaded into the lanes of the gel while the gel was submerged in 
1xTBE in a buffer chamber.  The TBE was kept at a constant 60 degrees Celsius.  The gel 
was run at 70 volts for 15 hours.  The gel was stained with ethidium bromide and 
subsequently washed with dH2O, then viewed under UV light.  Figure 20 illustrates a 
section of that gel containing FA1090 and Poly G variant samples.  The percentage of 
gradient viewed in the gel was calculated based on a linear gradient from 0 to 100% 
throughout the gel.  Here the denaturant solution is ~25% at the top and ~55% at the  
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Fig. 20: A small region of the nfsB gene was amplified using PCR with primers that 
added a GC-clamp.  Those PCR products are shown in the bottom panel taken 
from a 1% agarose gel.  The exact base pair size of each PCR product is labeled 
above each lane.  The DNA samples were separated using denaturing gradient 
gel electrophoresis.  The gradient was poured to achieve a 0% to 100% 
denaturant gradient.  The top panel represents a small portion of that gel and the 
percentage of denaturant was calculated based on a linear gradient.  The 
addition of guanines in the tract increases the Tm value; therefore the product 
travels further before it encounters a concentration of denaturant that creates 
single-stranded DNA.  This can be observed in the change from FA1090 (no G-
tract) to G6 then G7 then G8 and G10.  Poly G9 may have secondary structure 
that causes complications in denaturation, therefore observations for these 
samples is not as expected.  Poly G5 has additional base pairs to keep the gene 
in frame and these extra base pairs are also guanines.  This may account for the 
unexpected finding observed with Poly G5.        
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Figure 20 – DGGE of Poly G Variants 
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bottom.  The noticeable shifts in the bands can be contrasted to the PCR products viewed 
in a 1% agarose gel shown in the bottom panel where the DNA is aligned.  FA1090 DNA 
traveled the least in the gel because it contained no poly-guanine tract to impede 
denaturation.  A contrast of the distance traveled in the gel is observed in G6, G7, and G8 
DNA corresponding to the extra guanine impeding denaturation.  nfsB G10 DNA traveled 
the farthest in the gel as expected with a long guanine tract.  Light extra bands can be 
observed in some lanes that are most likely intermediates of denaturation.  DNA of nfsB 
G5 did not denature or travel as expected.  However, the sequence of nfsB G5 contains 
extra guanines added to keep the gene in frame.  These are separated from the 5 guanine 
tract by a thymine.  Therefore, G5 DNA is larger in size (206bp) and contains 3 extra 
guanines that will hinder denaturation more than expected with the 5 guanine tract alone.  
Thus nfsB G5 travels further than the 6 guanine tract and what is observed is most 
reliable.  The DNA of nfsB G9 is observed traveling slower in the gel than G8 but slightly 
faster than G7.  This DNA may contain secondary structure that further complicates the 
denaturing process.  Also, nfsB G8 may travel farther because like G5, it contains extra 
guanines before a thymine to maintain the open reading frame.  With DGGE and these 
samples, it looks as if the main target for study may be in lengths of 6, 7, and 8.   
It was hoped that the genetic basis for mutation in nfsB G7 mutants could be 
detected as single nucleotide deletions or insertions in the guanine tracts using nfsB G6, 
nfsB G7, and nfsB G8 as controls for DGGE.  However, surprising results were observed 
for numerous nfsB G7 NitR mutants tested with DGGE.  None of the mutants tested 
contained frame-shifting mutations in the guanine tract (data not shown).  Every DNA 
sample from the mutants contained the tract of 7 guanines because they traveled the same 
75
distance through the gel as the nfsB G7 control DNA.  Even though the hope was to 
observe frame-shifting mutations in nfsB G7 NitR mutants, the genetic basis for the 
mutant phenotype of the samples studied was not due to addition or deletion of guanines 
within the tract as expected.   
Analysis of nfsB G8 NitR mutants used DGGE and the gels were analyzed for a 
frame-shifting mutation.  Figure 21 illustrates one gel containing frame-shifting 
mutations resulting in altered migration/mobility in the gel.  DNAs from control samples 
of nfsB G7, nfsB G8, nfsB G9, and nfsB G10 were used as controls to define the 
expectations of denaturation in the gel.  Mutants isolated were picked from plates grown 
on GCK and freezer stocks were made.  These mutant isolates were arbitrarily named 
using G8 then the date found (month then day) and a number to identify, such as G8 
1112-1.  G8 mutants numbered 1112-1 to 1112-8 and 420-10 to 420-11 are viewed in this 
figure and the numbers above the lane signify the final number in the name designation.  
This gel was poured with a gradient that ranged from 25% to 75% denaturant solution 
and the portion of the gel viewed contains roughly 30% to 45% denaturing gradient 
calculated based on a linear gradient.  Mutants G8 1112-1 and G8 1112-6 traveled in the 
gel similar to the G8 control so must still contain 8 guanines in the poly-guanine tract and 
much like the nfsB G7 mutants the mutations lies outside the area of detection.  Mutant 
G8 1112-7 and mutant G8 420-11 contained a deletion of a guanine since they shifted to 
travel in the gel like nfsB G7.  The other mutants in this gel G8 1112-2 thru -5 and G8 
420-8 thru -10 contained a shift that is unidentifiable.  The DNA traveled farther than 
nfsB G8 DNA but not as far as nfsB G10 DNA.  These may be a true representation of a  
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Figure 21 – DGGE Detection of nfsB G8 Mutants 
Fig. 21: Denaturing gradient gel electrophoresis (DGGE) was used to detect single 
nucleotide additions or deletions due to frame-shifting mutations.  This will 
determine whether frame-shifting mutations are the genetic basis for the NitR
phenotype acquired in these nfsB G8 mutants.  In this case a gradient was 
poured to achieve a 25% to 75% of denaturant gradient throughout the gel.  The 
figure shows a portion of that gel with the percentages of denaturant calculated 
based on a linear gradient.  G7, G8, G9, and G10 serve as controls for 
unmutated Poly-G strains with select lengths of guanines in the tract.  Lanes 1-
11 are nfsB G8 nitrofuran resistant mutants arbitrarily numbered from the point 
of isolation.  Mutants #1 and #6 contain 8 guanines and the genetic basis for 
their mutant phenotype must not be due to frame-shifting.  Mutants #7 and #11 
have shifted in the gel and resemble a guanine tract of length 7; therefore these 
mutations were caused by the deletion of a base.  Mutants #2-5 and #8, #10 are 
shifted slightly from both G8 and mutants #1 and #6 and appear to be true poly-
G9 tract shifts.  
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poly-guanine tract with 9 guanines without the secondary structure.  This means that 
these mutants were created by the addition of a single guanine in the tract.  Many of these 
samples of nfsB G8 were mutated from a NitS phenotype to a NitR phenotype as a 
consequence of frame-shifting.  In the small sampling of nfsB G8 mutants including the 
ones shown here and others not shown (40 samples), about two-thirds (66.67%) of the 
mutants possessed an additional guanine (G9) while about one-sixth (16.67%) possessed 
a deletion (G7) and the other one-sixth (16.67%) the numbers of guanines in the tract 
were unchanged (G8).  It appears that by using DGGE, frame-shifting mutations in the 
poly-guanine tract of the reporter system can be detected by observing band-shifts 
because of the addition or deletion of a guanine.  
DNA sequencing of the nfsB region amplified by the GC-clamp primers for the 
NitR mutants verified the results in the DGGE gel.  The DNA sequence of the ~200 bp 
product was analyzed to determine the number of guanines in the tract, but this only 
analyzed the small region near the 5’ end of the gene and does not give any information 
about the rest of the coding region of the gene.  Mutants G8 1112-1 and -6 have 8 
guanines, while Mutant G8 1112-7 and Mutant G8 420-11 have 7 guanines.  Mutant G8 
1112-2 thru -5, Mutant G8 1112-8, and Mutant G8 420-10 underwent addition mutations 
and possess 9 guanines.  The mutants included contain the wide variety of mutations that 
cause a NitR phenotype, either addition or deletion of a nucleotide or a mutation found 
elsewhere in the nfsB gene.     
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Discussion
Overview 
 
Studies of the connection between DNA repair and phase variation have been 
hampered by the low spontaneous mutation frequencies to most agents that could be used 
to select for mutants in DNA repair pathways.  Also, there is no method of selection that 
has proved useful for measuring all types of phase variation prevalent in the gonococcus.  
A working knowledge of phase variation has also been hampered by the difficulty in 
observing variation in genes.  Many examples of phase variation are known in N. 
gonorrhoeae but the exact way that phase variation occurs is not clear.  The goal of this 
work was to create a reporter system that could allow for easy observable measurement 
by using a positive selection.  The selection process for growth versus non-growth in the 
presence of nitrofuran antimicrobials allowed for easy detection of gene expression.  A 
nitroreductase gene, nfsB, which was not phase variable, was modified by the insertion of 
the poly-guanine tract within its coding sequence.  Strains were created in this project 
that varied in the length of poly-guanine tract, and these strains were used to determine 
the effect of poly-G tract length on phase variability.   
 The results of the spontaneous mutation frequency plating experiments and the 
subsequent genetic analysis showed that nitrofurantoin resistance is a potential target for 
analyzing mutation in the gonococcus that is relevant to phase variation because the gene 
had a low inherent spontaneous mutation frequency.  Mutations occurred at a higher rate 
in the strains containing poly-guanine tracts and the frequency of mutation increased as 
the poly-guanine tract length increased within the range of 5 to 7 guanines.  The simplest 
explanation was that a long tract of similar nucleotides is prone to slipped-strand 
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mispairing during DNA replication, and DNA repair pathways in the gonococcus cannot 
repair these mistakes as efficiently.  However, these defects in repair of these 
homopolymeric tracts allowed for the phase variability of genes that can be advantageous 
at times for the bacteria to increase pathogenicity and evade host immunity.   
This mutation frequency data indicate that N. gonorrhoeae encodes one 
nitroreductase (nfsB) because a mutation in this gene resulted in resistance to nitrofurans 
and loss of nitroreductase activity.  Biochemical data were obtained that supports this 
conclusion (Figure 3).  Comparison of the nitroreductase activity of cell lysates of wild-
type FA1090 and a NitR mutant M1 showed that a mutation in nfsB alone will result in 
the loss of activity.  Cell lysate controls that did not contain the co-factor NADPH show 
that without the important co-factor present there is no nitroreductase activity.  Together 
this indicates that NfsB was the only oxygen-insensitive nitroreductase found in the 
gonococcal genome and any reduction of nitrofurans observed was solely from NfsB. 
Sequence alignment analysis of numerous NfsB and NfsB-like proteins from 
various bacteria (Figure 2) indicated that the gonococcal NfsB contained stretches of 
amino acids that are conserved and functionally important in well characterized 
nitroreductases.  Most notably is the region of conserved amino acids near the N-
terminus, which has been hypothesized to be the FMN-binding site [57].  Sequence 
alignment also led to the hypothesis that the first amino acids are not important to 
function because there was little conservation observed in the extreme N-terminus 
(Figure 2).  This suggested that the nitroreductase gene could be manipulated by 
inserting a poly-guanine tract at the very beginning of the coding region.   
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Poly-guanine tracts of lengths 5 to 10 and 12 were added to nfsB in FA1090 to 
create 7 variant strains.  These new strains allowed us to monitor the phase variability of 
a poly-guanine tract because of its inclusion in a gene encoding a protein whose 
expression can be positively selected.   
Nitroreductases have been used as reporter systems for chemical mutagenesis 
studies in Salmonella. A series of plasmids was constructed containing the E. coli genes 
nfsA and nfsB. These plasmids were used to create Salmonella typhimurium tester strains 
that were used to study the mutagenicity of various nitro-substituted compounds [73].  
Biochemical activity of the nitroreductases was determined using absorbance levels at a 
wavelength of 400nm much like in this project.  This method could be used to 
characterize biochemical activity of various nitroreductases to many of these nitro-
aromatic compounds.  Each of these new strains created in this project was subjected to 
biochemical analysis.  All the strains possessed a level of nitrofuran reductase activity.  
However, some required increased incubation times to visualize the activity, suggesting 
that the alterations at the amino-terminus effected enzymatic function, protein expression 
levels, or protein stability.  All strains appeared to have enough activity to impart 
nitrofuran sensitivity on the gonococcus.  Even though it was hypothesized that 
tampering with the amino acid sequence at the N-terminus would be harmless, these 
activities observed may be due to the glycines added to the N-terminus of the 
nitroreductase by the poly-guanine tract.  There also could be a difference in expression 
level of nitroreductase among the strains.  Also, because the lysate samples are not 
purified, other proteins may be expending the NADPH.  The modified nitroreductases 
may reduce nitrofuran and NADPH slower, and these contaminating proteins are 
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exhausting the NADPH before the nitroreductase can use the co-factor.  Therefore, an 
abundance of NADPH may need to be added to our assay mixes to obtain truer measures 
of nitroreductase activity.  However, nfsB G7 possessed an activity similar to FA1090 
(Figure 13) and was a useable strain for the reporter system.     
The reporter system works because mutations in nfsB were obtained when wild-
type nitrofuran sensitive gonococci were plated on nitrofuran-containing media and the 
resulting mutants lack nitroreductase activity.  This creates a positive selection where our 
mutants of interest grow in the presence of the antimicrobial at the MIC of 3 µg/mL.   
The spontaneous mutation frequency was assayed for every poly-guanine variant 
strain (Figure 19).  It was hypothesized that the minimal length of guanines to observe an 
increase in mutation frequency would be 10, because surface proteins like LOS undergo 
phase variation due to poly-guanine tracts lengths of 10 or higher [31, 32].  However, the 
observations here show a minimum length of guanine tract to be smaller, around 6 or 7 
guanines.  Strain nfsB G5 had a mutation frequency roughly 10-fold higher than wild-
type, then strain nfsB G6 was 10-fold higher than that, and finally strain nfsB G7 
possessed a mutation frequency 10-fold higher still.  The mutation frequencies of poly-
guanine tracts of increased lengths plateau around 10-4. The minimal length important for 
phase variability appeared to be shorter than expected.  Strains nfsB G7 and nfsB G8 
could be important in future work on phase variation using these reporter system strains.      
Observations of the mutation frequency of the varying poly-G tract lengths reveal 
that nfsB G7 has the highest mutation frequency.  The mutation frequency observed may 
be higher than any of the other poly-G strains due to the activity of the nitroreductase.  
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The strain with 7 guanines was the only strain to have activity similar to wild-type 
activity and higher activity may place more pressure for mutation to a NitR phenotype.   
When performing studies using this reporter system, it would be important to note 
which mutants gained the NitR phenotype due to frame-shifting mutations.  Denaturing 
gradient gel electrophoresis (DGGE) proved to be a reliable method to detect frame-
shifting mutants fairly quickly.  DGGE was able to detect insertion or deletions of 
guanines in the poly-guanine tract when a frame-shift mutation is responsible for the 
observed change in phenotype.  Results in Figure 21 showed that detection of nucleotide 
insertions or deletions in the poly-guanine tract of strain nfsB G8 was possible.  Using 
nfsB G8 as the reporter strain, it would be possible to easily detect mutants, arising from 
plating assays with nitrofuran antimicrobials, which contain frame-shift mutations due to 
the high resolution gel when using DGGE.    
 
Future Work 
Now that a reporter system for poly-guanine tract analysis has been created, it can 
be used to study phase variation and the effect of the various DNA repair pathways on 
this mutation.  This system could have implications in determining what proteins and 
genes act upon homopolymeric nucleotide tracts.  These genes/proteins could be 
important or necessary for phase variation.  And because of proposed mechanisms of 
action of these proteins, it may provide further insight into DNA repair pathways in N. 
gonorrhoeae, plus elucidate connections between DNA repair and phase variation.   
Previously described was a reporter system based on the HpuA/B hemoglobin 
receptors [43].  Tn-mutagenesis defined genes/proteins important for phase variation of 
the hemoglobin receptor in N. meningitidis. This reporter system functioned like the one 
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created in this project because it was based on phase-variable expression of the 
hemoglobin receptor that was essential for growth of the bacteria.  Much like these 
others, genetic studies using this reporter system for an output of manipulation can lead 
to better understanding of a pathway or mechanism.  The focus of this system will be on 
further defining how gonococci use phase variation and a better understanding of how it 
is accomplished.   
Knock-out mutants of proposed genes or proteins can be made and the mutation 
frequency of a poly-guanine strain can be assayed through plating experiments with 
nitrofurantoin.  An observed change in mutation frequency would show that this 
gene/protein affects homopolymeric nucleotide tracts.  If a strain such as nfsB G8 is to be 
used in such studies, the mutation frequency is already known (Figure 19; Table 7).  
DGGE can also be used to determine if frame-shifting mutations have occurred.  Random 
transposon mutagenesis of the gonococcal genome as described by Kleckner et al. (1991), 
[74] can lead to discovery of genes important to phase variation through homopolymeric 
nucleotide tracts using the nitroreductase/poly-guanine tract reporter system from this 
project.  These may be genes previously known to be involved in phase variation or DNA 
repair or genes that had not been previously connected.  These genes that appear to have 
a connection to phase variation can be further analyzed and a more defined picture of 
phase variation can be determined.   
A potential problem that may arise in using this reporter system requires extra 
vigilance when performing plating assays.  The reporter system relies on the NitS
phenotype of the strains.  And with the added poly-guanine tracts in the nitroreductase, 
mutation frequency is increased.  Therefore, these strains can acquire a NitR phenotype at 
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a considerably higher rate than is possible for strains harboring wild-type nfsB. When 
performing assays, it is important to assure that the strains are NitS or the mutation 
frequency outputs of the assay will be unreliable.  This is especially imperative with the 
longer guanine tracts such as 10 or 12, because it can be easy to streak the strains onto 
GCK and pick a colony that has undergone a frame-shift mutation.   
This reporter system may have limitations associated with using a poly-guanine 
tract.  While many suspected phase variation genes do use poly-guanine tracts, others 
also use poly-cytosine tracts and pentameric repeats.  This nitroreductase reporter system 
focuses on poly-guanine tracts, but any genes/proteins found to alter mutation frequency 
of poly-guanine tracts most likely will have the same mode of action on any type of 
homopolymeric tract.  Mutation and phase variability of poly-guanine tracts should be 
equal to variability of poly-cytosine tracts, because of the dual nature of DNA replication.  
While one strand of the DNA would be replicating using a poly-guanine tract, the other 
strand is replicating using a poly-cytosine tract.  Plus any knowledge gained could be 
useful for understanding any type of phase variation.  In future work, the nfsB coding 
region could be modified to contain poly-pentameric runs to replace the poly-guanine 
tracts.  These strains could be used to study pentameric repeats using a positive selection.     
Phase variation in genes responsible for the expression of various cell surface 
antigens is an important aspect of the pathogenesis of N. gonorrhoeae. Phase variation 
may be important for the bacteria to attach to host cells and then make a switch to 
become invasive.  Expression of Opa proteins is essential for attachment [12, 13] and the 
variable expression of type IV pili is important for initial attachment and a major 
antigenic determinant [17].     Frame-shifting in homopolymeric nucleotide tracts is a 
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common and important mechanism to accomplish phase variation which can lead to 
varying protein expression patterns.  Surface proteins that are encoded by genes 
containing homopolymeric nucleotide tracts and undergo phase variation include LOS 
[31, 32], pilC [22], and iron-utilization receptors FetA [34] and HpuAB and HmbR [35 –
37].  Opa-coding genes also undergo phase variation due to a similar mechanism by 
altering the number of pentameric repeats at the start of the genes [14].  The propensity 
for frame-shifting mutations in homopolymeric nucleotide tracts supports the theory that 
pathogenic gonococci use frame-shift mutations to accomplish antigenic variation.  This 
creates more precedent for the use of a poly-guanine tract dependent reporter system for 
the future studies of the connection of phase variation and DNA repair. The power of the 
reporter system will be to allow for deeper and clearer understanding of how phase 
variation occurs and how the bacterium effectively uses phase variability. 
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